Fact-checked by Grok 2 weeks ago

Sensorineural hearing loss

Sensorineural hearing loss (SNHL) is a type of hearing impairment resulting from damage to the inner ear structures, particularly the cochlea's hair cells, the auditory nerve, or the central nervous system pathways that process sound signals.^[1]^[2] This condition accounts for the majority of permanent hearing loss cases and is typically irreversible because human inner ear hair cells do not regenerate, though emerging gene therapies as of 2025 show promise in preclinical and early clinical trials.^[1]^[3]^[4] Unlike conductive hearing loss, which involves outer or middle ear blockages, SNHL disrupts the sensory or neural transmission of sound, often leading to difficulties in understanding speech, especially in noisy environments.^[2] SNHL can arise from a variety of causes, broadly categorized as congenital or acquired. Congenital forms may be syndromic (associated with genetic syndromes) or nonsyndromic, while acquired causes include age-related degeneration (presbycusis), exposure to excessive noise (noise-induced hearing loss), ototoxic medications (such as certain antibiotics like gentamicin), infections (e.g., meningitis), head trauma, autoimmune disorders, and tumors like vestibular schwannoma.^[1]^[2] Noise-induced SNHL occurs when intense sounds damage cochlear hair cells by causing excessive bending of their stereocilia, leading to cell death; sounds above 85 decibels (dBA), such as those from concerts or machinery, pose significant risk.^[3] Risk factors encompass aging (prevalence doubles every decade after age 20, affecting nearly all individuals over 80), hereditary predisposition, occupational or recreational noise exposure, and certain systemic conditions. As of 2025, over 1.5 billion people worldwide live with some degree of hearing loss, the majority attributable to SNHL.^[1]^[2]^[5] Common symptoms of SNHL include gradual or sudden reduction in hearing acuity, often starting with high-frequency sounds, muffling of speech, tinnitus (ringing in the ears), aural fullness, and balance issues like disequilibrium or vertigo in some cases.^[1]^[2] For instance, presbycusis typically presents as difficulty discerning consonants and understanding words in background noise, while sudden SNHL—defined as a loss of 30 dB or more over three contiguous frequencies within 72 hours—may affect one ear and is considered a medical emergency.^[1]^[2] Epidemiologically, SNHL is widespread; in the United States, sudden SNHL incidence ranges from 5 to 27 cases per 100,000 people annually, and noise contributes to about 16% of adult hearing loss globally.^[1] Diagnosis involves audiometric testing, such as pure-tone audiometry to measure hearing thresholds and tympanometry to assess middle ear function, supplemented by tuning fork tests (e.g., Rinne and Weber) and imaging like MRI for underlying pathologies.^[1] Treatment varies by etiology and severity but focuses on symptom management and rehabilitation, as the loss is often permanent. Acute cases, particularly sudden SNHL, may respond to oral corticosteroids (e.g., prednisone at 1 mg/kg/day) within the first two weeks, with 32-65% spontaneous recovery possible.^[1] For chronic SNHL, options include hearing aids to amplify sound or cochlear implants for profound losses exceeding 70-80 dB; prevention strategies emphasize avoiding loud noises through ear protection and regular hearing screenings.^[1]^[3] Early intervention improves quality of life, reducing risks of social isolation and cognitive decline associated with untreated hearing loss.^[1]

Overview

Definition and types

Sensorineural hearing loss (SNHL) is a permanent type of hearing impairment caused by damage to the inner ear structures, particularly the cochlea's hair cells, or the auditory nerve, which prevents the proper transmission of sound vibrations from the cochlea to the brain.^[1] This damage disrupts the conversion of mechanical sound waves into electrical signals that the brain interprets as sound, leading to difficulties in hearing faint or quiet sounds and often affecting speech understanding. SNHL is distinct from conductive hearing loss, which results from obstructions or damage in the outer or middle ear that block sound waves from reaching the inner ear, such as earwax buildup or middle ear infections.^[1] In contrast, SNHL involves pathology beyond the middle ear, with no air-bone gap observed on audiometric testing. Mixed hearing loss occurs when both conductive and sensorineural components are present simultaneously.^[6] Classifications of SNHL include distinctions by laterality and symmetry: unilateral (affecting one ear) or bilateral (affecting both ears), and symmetric (similar severity in both ears) or asymmetric (varying severity between ears).^[7] By onset, it can be congenital (present from birth) or acquired (developing after birth).^[8] Regarding progression, SNHL may be stable (non-worsening) or progressive (gradually deteriorating over time).^[8] Severity is determined by pure-tone average hearing thresholds across key frequencies (500, 1000, 2000, and 4000 Hz): mild (26–40 dB), moderate (41–60 dB), severe (61–80 dB), or profound (≥81 dB).^[9] The concept of what is now termed SNHL, often referred to as nerve deafness in early descriptions, emerged in 19th-century medical literature amid debates on congenital and acquired auditory impairments. Modern classification systems, including severity grading, evolved from audiometric standards set by the World Health Organization in the early 1990s.^[10]

Epidemiology

Sensorineural hearing loss (SNHL) represents a significant global health burden, affecting approximately 430 million people worldwide with disabling hearing impairment as of 2025, the majority of which is sensorineural in nature. This prevalence equates to over 5% of the world's population requiring rehabilitation, with projections estimating that by 2050, nearly 2.5 billion individuals will experience some degree of hearing loss, including over 700 million with disabling forms primarily due to aging populations and persistent risk factors.^[5]^[11] Age-related SNHL, known as presbycusis, is the predominant form in older adults, accounting for a substantial portion of cases and affecting about one-third of individuals aged 65 to 74 and nearly half of those over 75. The incidence of disabling hearing loss, largely sensorineural, increases markedly with age, from around 10% in adults aged 55 to 64 to 22% in those 65 to 74 and 55% in individuals 75 and older.^[12]^[13] Demographic disparities exacerbate the burden, with males experiencing higher rates due to greater occupational and recreational noise exposure. Regional variations show elevated prevalence in low- and middle-income countries, where untreated infections contribute significantly and nearly 80% of people with disabling hearing loss live, compared to higher-income settings. Congenital SNHL affects approximately 1 to 3 per 1,000 live births, underscoring its impact from early life.^[14]^[15]^[16]^[5] Recent trends indicate post-2020 increases in SNHL incidence linked to COVID-19 infection and associated ototoxicity, particularly sudden sensorineural hearing loss among young adults, with risks rising notably from 2020 to 2022. The World Health Organization's 2025 updates highlight noise-induced SNHL as a growing concern in urban youth, with over 1 billion young adults at risk from unsafe listening practices involving personal audio devices.^[17]^[5]

Signs and symptoms

Auditory manifestations

Sensorineural hearing loss (SNHL) primarily manifests as difficulty understanding speech, especially in noisy environments, where individuals struggle with discriminating speech signals from background noise due to impaired auditory processing. This core symptom arises from damage to the cochlea or auditory nerve, leading to reduced clarity in perceiving nuanced sound patterns essential for communication. In daily life, affected individuals may frequently ask others to repeat themselves, withdraw from social gatherings, or rely on visual cues like lip-reading to compensate for the deficit.^[2]^[7] The auditory effects often vary by the frequency range of the loss. High-frequency SNHL, the most common form, impairs perception of consonants such as /s/, /f/, /sh/, and /th/, resulting in muffled or indistinct speech that sounds blurred or slurred. In contrast, low-frequency SNHL affects vowel sounds like /a/, /e/, and /o/, which carry much of the intensity and rhythm in speech, leading to challenges in distinguishing words with similar vowel patterns and altering the prosody of spoken language. These frequency-specific deficits highlight how SNHL disrupts the spectral components critical for intelligible conversation.^[18]^[19] The severity of SNHL influences the extent of auditory impairment, progressing from mild to profound levels. In mild cases (26–40 dB hearing level), subtle mishearing of words or soft speech occurs, particularly in quiet settings, allowing functional hearing in ideal conditions. Moderate to severe losses (41–90 dB) intensify speech comprehension difficulties, making conversations laborious even without noise. Profound SNHL (>91 dB) results in near-complete deafness, where only very loud sounds are detectable, severely limiting auditory input.^[20]^[8] Associated auditory issues include recruitment, an abnormal rapid growth in perceived loudness for sounds above the hearing threshold, which can make moderate noises uncomfortably intense despite overall hearing reduction. Hyperacusis, characterized by intolerance to ordinary environmental sounds, affects 40-86% of individuals with comorbid tinnitus in cases of auditory pathologies including SNHL, exacerbating discomfort in everyday auditory exposure.^[21] Tinnitus, a frequent co-occurrence, presents as phantom noises like ringing, further complicating auditory experiences.^[22]^[1]

Non-auditory effects

Sensorineural hearing loss (SNHL) often affects the vestibular system due to the anatomical proximity of the cochlea and vestibular organs within the inner ear, leading to symptoms such as dizziness, imbalance, and vertigo in approximately 28-57% of cases involving sudden onset SNHL.^[23] These vestibular disturbances can manifest as acute vertigo attacks, contributing to falls and reduced mobility, particularly in older adults where balance impairment exacerbates daily functional limitations.^[24] Beyond balance issues, SNHL is associated with cognitive decline, including an elevated risk of dementia that is nearly twofold higher in affected individuals compared to those without hearing loss, as evidenced by meta-analyses of longitudinal studies.^[25] Untreated SNHL contributes to this risk through mechanisms like sensory deprivation and increased cognitive load from auditory processing deficits, while communication barriers often lead to social isolation and heightened depressive symptoms, with affected adults reporting more negative emotional responses and situational limitations.^[26]^[27] In children, SNHL significantly impacts developmental milestones, causing delays in language acquisition that persist even with mild to severe degrees of loss, resulting in depressed expressive and receptive skills relative to hearing peers.^[28] These language delays frequently translate to academic underperformance, including challenges in literacy and classroom participation, underscoring the need for early intervention to mitigate long-term educational disparities.^[29] Overall, SNHL diminishes quality of life, as measured by tools like the Hearing Handicap Inventory for Adults (HHIA), where individuals commonly report reduced social participation scores indicative of mild to severe handicaps in emotional and situational domains.^[30] For instance, higher HHIA totals correlate with greater perceived barriers to social engagement, highlighting the broader psychosocial toll of the condition.^[31]

Causes

Genetic factors

Genetic causes account for approximately 50-60% of cases of sensorineural hearing loss (SNHL) in childhood, with autosomal recessive inheritance being the most prevalent pattern among prelingual forms.^[32] Congenital SNHL affects about 1-2 per 1,000 newborns, as identified through universal newborn hearing screening programs.^[33] These genetic etiologies can be classified as nonsyndromic, where hearing loss occurs in isolation, or syndromic, involving additional clinical features. Among nonsyndromic forms, mutations in the GJB2 gene, encoding connexin 26, are the most common, responsible for 20–50% of congenital cases depending on population and ethnicity, and more than half of autosomal recessive nonsyndromic SNHL overall.^[34]^[35] The DFNB1 locus, primarily involving GJB2 variants, exemplifies autosomal recessive inheritance (DFNB), which predominates in genetic childhood SNHL.^[36] Autosomal dominant patterns (DFNA) are less frequent, typically causing postlingual progressive loss, while X-linked (DFNX) and mitochondrial forms are rarer.^[37] Mutations in the OTOF gene, encoding otoferlin, are linked to auditory neuropathy spectrum disorder, a subset of SNHL characterized by disrupted synaptic transmission in the inner ear.^[38] Mitochondrial inheritance contributes to SNHL through mutations like A1555G in the MT-RNR1 gene, which predisposes individuals to nonsyndromic hearing loss and heightened sensitivity to aminoglycoside ototoxicity.^[39] In syndromic SNHL, Usher syndrome combines congenital to severe SNHL with retinitis pigmentosa leading to vision loss, inherited mostly autosomally recessive.^[40] Waardenburg syndrome features SNHL alongside pigmentation abnormalities, such as heterochromia iridis or white forelock, and follows autosomal dominant transmission in most cases.^[41]

Acquired factors

Acquired sensorineural hearing loss (SNHL) encompasses a range of non-genetic etiologies that develop after birth, often due to environmental exposures, medical interventions, or physiological insults that damage the inner ear or auditory nerve. These factors are modifiable in many cases through preventive measures, contrasting with congenital or hereditary forms. Common contributors include noise exposure, ototoxic medications, infections, aging, trauma, autoimmune processes, neoplasms, and perinatal complications, each leading to irreversible hair cell loss or neural degeneration.^[1] Noise exposure is a leading environmental cause of acquired SNHL, particularly from occupational or recreational sources exceeding safe thresholds. Prolonged exposure to sounds above 85 decibels (dB) or impulse noises surpassing 140 dB can trigger acoustic trauma, resulting in permanent high-frequency hearing deficits. Globally, occupational noise accounts for approximately 16% of disabling hearing loss among adults, affecting millions through cumulative damage to cochlear hair cells.^[42]^[43] Ototoxic drugs represent a significant iatrogenic risk, damaging inner ear structures via mechanisms such as oxidative stress or direct toxicity. Aminoglycoside antibiotics, including gentamicin, carry a 20-50% risk of ototoxicity, often manifesting as bilateral, high-frequency SNHL in vulnerable patients like those with renal impairment. Cisplatin, used in chemotherapy, induces hearing loss in up to 60-90% of pediatric cases and 23-50% of adults, depending on cumulative dose and co-administration with other agents. Loop diuretics, such as furosemide, contribute to transient or permanent SNHL in 6-7% of users, particularly when combined with other ototoxins or in high doses.^[44]^[45]^[46] Infections can precipitate acute or progressive SNHL by direct viral invasion of the cochlea or secondary inflammation. Bacterial or viral meningitis leads to SNHL in 10-30% of cases, with higher rates in children due to labyrinthitis ossificans or neural involvement. Mumps virus causes unilateral SNHL in approximately 0.005–0.5% of infections, typically sudden and sensorineural in nature, though often mild to moderate. Studies from 2020-2025 indicate that COVID-19 is associated with auditory sequelae, including SNHL, in 5-20% of symptomatic patients, potentially linked to viral neurotropism or vascular effects.^[47]^[48]^[49] Aging, or presbycusis, drives acquired SNHL through cumulative oxidative stress and vascular changes in the cochlea, affecting over 25% of adults aged 65 and older. Head trauma, especially temporal bone fractures from severe impacts, disrupts the auditory nerve or inner ear in up to 30-50% of cases, leading to immediate or delayed SNHL. Autoimmune inner ear disease (AIED) involves immune-mediated inflammation, causing rapid, progressive, often fluctuating bilateral SNHL that may respond to immunosuppressive therapy if diagnosed early. Neoplasms, such as vestibular schwannoma (acoustic neuroma), can cause progressive unilateral SNHL by compressing the auditory nerve.^[18]^[50]^[51]^[1] Perinatal factors heighten SNHL risk in neonates, particularly among preterm or low-birth-weight infants. Prematurity independently increases susceptibility, with prevalence rising as gestational age decreases below 32 weeks due to immature cochlear development and intensive care exposures. Hyperbilirubinemia, or neonatal jaundice, correlates with SNHL through bilirubin-induced neurotoxicity, especially when levels exceed 20 mg/dL or require exchange transfusion. Low birth weight (<1500 g) elevates risk via associated complications like hypoxia or mechanical ventilation, observed in up to 2-5% of very low-birth-weight infants.^[52]^[53]^[54]

Pathophysiology

Inner ear mechanisms

Sensorineural hearing loss (SNHL) primarily arises from damage to the sensory structures within the cochlea, particularly the hair cells that transduce mechanical sound vibrations into neural signals. The cochlea houses two types of hair cells: inner hair cells (IHCs) and outer hair cells (OHCs). IHCs function as primary sensory transducers, converting basilar membrane motion into neurotransmitter release at ribbon synapses that convey auditory information to spiral ganglion neurons of the auditory nerve.^[55] In contrast, OHCs actively amplify weak sounds through electromotility, a process driven by conformational changes in the motor protein prestin in response to receptor potentials, which enhances cochlear sensitivity and sharpens frequency tuning.^[56] Loss of OHCs diminishes this amplification, leading to reduced dynamic range and elevated thresholds, while IHC loss disrupts signal transmission, often resulting in more severe auditory deficits.^[57] A key feature of cochlear pathology in SNHL is the development of dead regions, which are contiguous zones of the organ of Corti where IHCs or their associated neurons are sufficiently dysfunctional that they cannot effectively contribute to sound encoding for specific frequencies.^[58] These regions typically occur at frequencies where hearing thresholds exceed 70-80 dB HL, as off-frequency hair cells with lower thresholds may respond to tones but with poor fidelity, leading to broadened auditory filters and diminished frequency selectivity.^[58] Consequently, sounds in dead regions are misrepresented by adjacent functional areas, contributing to distorted pitch perception and reduced speech intelligibility in noise.^[58] The underlying mechanisms of hair cell damage in SNHL involve multiple cellular stressors that culminate in cell death or dysfunction. Noise exposure and ototoxins, such as aminoglycoside antibiotics and cisplatin, trigger oxidative stress through reactive oxygen species (ROS) accumulation, activating pathways like JNK and p38 MAPK that promote apoptosis in hair cells.^[59] This oxidative damage often targets stereocilia, the mechanosensitive projections on hair cell apical surfaces, causing tip-link breakage and impaired mechano-transduction—the process by which ion channels open in response to stereocilia deflection to depolarize the cell.^[60] Stereocilia injury reduces the hair cell's ability to detect basilar membrane vibrations, further exacerbating signal loss.^[60] The basilar membrane's tonotopic organization maps sound frequencies along its length, with high frequencies at the base and low frequencies at the apex, enabling frequency-specific activation of hair cells in healthy cochleae.^[61] Neural tuning curves, which reflect the frequency selectivity of auditory nerve fibers innervating these hair cells, are sharply peaked in normal ears, allowing precise discrimination of close frequencies.^[61] In SNHL, hair cell loss—particularly of OHCs—broadens these tuning curves by reducing active mechanical sharpening, resulting in poorer frequency resolution and increased spread of excitation across the cochlea.^[62] This broadening correlates with the degree of hearing loss and contributes to central auditory processing challenges downstream.^[62]

Neural components

Sensorineural hearing loss (SNHL) can involve disruptions beyond the cochlea, extending to the auditory nerve and central auditory pathways, where synaptic, neural, and cortical changes impair sound transmission and processing.^[63] A key neural component is cochlear synaptopathy, often termed "hidden hearing loss," which arises from damage to the ribbon synapses connecting inner hair cells to auditory nerve fibers, without affecting pure-tone thresholds. This condition is exemplified by noise-induced cochlear neuropathy, where even moderate noise exposure leads to selective loss of these synapses, resulting in difficulties understanding speech in noisy environments despite normal audiograms. The prevalence of cochlear synaptopathy in humans remains uncertain and is an active area of research, primarily inferred from animal models and limited human studies showing associations with noise exposure and difficulties in speech perception in noise.^[63]^[64]^[65] Diagnosis of cochlear synaptopathy in humans is challenging due to the lack of a standardized clinical test as of 2025, with research focusing on advanced auditory brainstem response measures and perceptual tests.^[66] Auditory nerve pathology contributes to retrocochlear forms of SNHL, where lesions disrupt nerve fiber integrity and signal conduction. Acoustic neuroma, a benign tumor on the vestibulocochlear nerve, compresses auditory nerve fibers, leading to progressive unilateral hearing loss, tinnitus, and balance issues due to impaired neural transmission. In auditory neuropathy spectrum disorder (ANSD), demyelination or axonal degeneration of the auditory nerve prevents synchronized neural firing, resulting in poor speech perception despite preserved cochlear function; this disorder accounts for approximately 5-15% of pediatric SNHL cases.^[67]^[68]^[69] Central auditory effects in SNHL involve reorganization of the auditory cortex and brainstem pathways, altering sound processing. Hearing loss triggers maladaptive plasticity in the auditory cortex, where reduced input leads to expanded representation of unaffected frequencies and heightened neural gain, often manifesting as tinnitus through aberrant hyperactivity. This reorganization also impairs temporal processing, diminishing the ability to resolve rapid acoustic changes essential for speech discrimination.^[70]^[71]^[72] The vestibulocochlear nerve (cranial nerve VIII) is particularly vulnerable to compression or ischemia, exacerbating SNHL through direct neural compromise. Tumors or vascular anomalies can compress the nerve, while ischemic events, such as infarction in the anterior inferior cerebellar artery territory, cause acute hearing loss by disrupting nerve perfusion and conduction. These pathologies highlight the nerve's role in integrating auditory and vestibular signals, with ischemia often presenting as sudden, profound unilateral SNHL accompanied by vertigo.^[73]^[74]^[75]

Diagnosis

History and examination

The evaluation of sensorineural hearing loss (SNHL) begins with a detailed case history to identify potential etiologies and guide differential diagnosis. Key elements include the onset of hearing loss, which may be sudden (defined as occurring over 72 hours or less) or gradual and progressive, and its laterality (unilateral or bilateral).^[76]^[1] Family history is essential to assess for genetic predispositions, such as hereditary syndromes, while inquiries into occupational or recreational noise exposure, head trauma, or barotrauma help identify acquired causes.^[29] A review of medications, particularly ototoxic agents like aminoglycosides, loop diuretics, or chemotherapy drugs, is critical, as is noting associated symptoms such as tinnitus, vertigo, disequilibrium, aural fullness, or focal neurologic deficits.^[1]^[7] Otoscopy, a visual inspection of the external auditory canal and tympanic membrane using an otoscope, is performed to rule out external or middle ear pathologies that could mimic or contribute to hearing loss. In pure SNHL, the otoscopic findings are typically normal, with no evidence of cerumen impaction, infection, perforation, or neoplasms.^[76]^[29] This step helps differentiate SNHL from conductive hearing loss, though adjunctive tests like tympanometry may be used briefly to exclude middle ear effusion if indicated.^[1] The physical examination extends to bedside tuning fork tests using a 512-Hz fork to further characterize the hearing loss. In the Rinne test, air conduction is compared to bone conduction; a positive Rinne (air conduction better than bone conduction) supports SNHL, while the Weber test involves placing the vibrating fork on the midline forehead, with sound lateralizing to the better-hearing ear in unilateral SNHL.^[76]^[29] A comprehensive cranial nerve assessment, particularly of nerves I through XII, is also conducted as part of a head and neck examination to identify any associated neurologic involvement, though findings are often normal in isolated SNHL.^[1] Red flags in the history and examination, such as sudden unilateral hearing loss or accompanying vertigo and neurologic symptoms, necessitate urgent referral to otolaryngology for timely intervention, potentially including corticosteroids within two weeks of onset to improve recovery chances. Significant asymmetry (e.g., ≥15 dB at 3000 Hz) requires prompt referral for evaluation and imaging.^[76]^[29]

Audiometric tests

Audiometric tests are essential for confirming the presence of sensorineural hearing loss (SNHL) and quantifying its severity and configuration, distinguishing it from conductive losses through objective and behavioral measures. These assessments evaluate the integrity of the cochlea and auditory nerve, providing thresholds and patterns that guide diagnosis and management.^[77] Pure-tone audiometry (PTA) is the cornerstone of audiometric evaluation, measuring hearing thresholds for pure tones presented via air conduction (headphones) and bone conduction (vibrator on the mastoid). In SNHL, thresholds overlap between air and bone conduction with an air-bone gap typically less than 10 dB hearing level (dB HL), confirming the sensorineural origin without middle ear involvement.^[77] A classic audiometric pattern in many cases of SNHL, such as age-related presbycusis or noise-induced loss, is a bilateral, gently to steeply sloping high-frequency configuration, where thresholds worsen progressively above 2 kHz, reflecting damage to basal cochlear structures.^[1] This test quantifies the degree of loss—mild (26-40 dB HL), moderate (41-55 dB HL), severe (71-90 dB HL), or profound (>90 dB HL)—based on the average of thresholds at 500, 1000, 2000, and 4000 Hz.^[78] Speech audiometry complements PTA by assessing functional hearing for speech, measuring speech detection threshold (SDT), speech recognition threshold (SRT), and word recognition score (WRS) using phonetically balanced word lists presented at comfortable levels. In SNHL, particularly cochlear forms, WRS is disproportionately reduced compared to pure-tone thresholds due to impaired frequency resolution and temporal processing; for instance, severe SNHL often yields WRS below 20%, indicating over 80% loss in word recognition even at suprathreshold levels.^[79] This discrepancy helps differentiate SNHL from purely conductive losses, where WRS typically aligns better with amplified thresholds.^[80] Objective electrophysiological tests like otoacoustic emissions (OAEs) and auditory brainstem response (ABR) provide non-behavioral confirmation of SNHL components. Transient evoked OAEs (TEOAEs) and distortion product OAEs (DPOAEs), generated by outer hair cells, are typically absent or significantly reduced in cochlear SNHL, indicating outer hair cell dysfunction even if behavioral thresholds are only mildly elevated.^[81] ABR, which records neural synchrony along the auditory pathway in response to clicks or tones, evaluates neural integrity; in pure cochlear SNHL, wave latencies and amplitudes may show elevated thresholds but preserved morphology, whereas retrocochlear involvement prolongs I-V interpeak latency.^[82] These tests are particularly valuable in infants, uncooperative patients, or when behavioral responses are unreliable.^[83] To identify cochlear dead regions—areas of inner hair cell loss that contribute to poor speech perception in SNHL—the threshold equalizing noise (TEN) test masks pure tones with broadband noise calibrated to equalize audibility across frequencies. A dead region is indicated if the masked tone threshold exceeds the unmasked threshold by more than 10 dB or rises above the noise level by 10 dB, highlighting regions where off-frequency listening cannot compensate, often in sloping high-frequency losses.^[84] This test informs hearing aid fitting by suggesting avoidance of amplification in dead regions to prevent distortion.^[85]

Imaging and advanced diagnostics

Imaging plays a crucial role in evaluating sensorineural hearing loss (SNHL) when structural abnormalities or retrocochlear pathology are suspected, particularly in cases of unilateral, asymmetric, or sudden-onset hearing loss. These indications warrant imaging to identify potential etiologies such as vestibular schwannoma or temporal bone trauma, as symmetric bilateral SNHL is less likely to yield positive findings on routine scans.^[86]^[87]^[88] Magnetic resonance imaging (MRI) serves as the gold standard for detecting retrocochlear lesions like acoustic neuroma (vestibular schwannoma), which can present with unilateral SNHL. Gadolinium-enhanced T1-weighted sequences provide high sensitivity, approximately 95-100%, for identifying these tumors by enhancing the solid components of the lesion within the internal auditory canal or cerebellopontine angle. Non-contrast high-resolution T2-weighted imaging can also detect such lesions with 84-100% sensitivity in screening contexts, though gadolinium remains preferred for definitive evaluation. Abnormal auditory brainstem response (ABR) findings may further prompt MRI to rule out retrocochlear involvement.^[89]^[90]^[91] Computed tomography (CT) of the temporal bone is particularly useful for assessing bony structures in SNHL associated with trauma or ossification processes. High-resolution CT excels at delineating fractures of the otic capsule, which occur in approximately 5% of temporal bone fractures and often lead to profound SNHL, as well as labyrinthine ossification that may complicate cochlear implantation. It provides detailed visualization of cochlear anatomy and the facial nerve canal, aiding in preoperative planning for cases like post-traumatic ossifying labyrinthitis.^[92]^[93]^[94]^[95] Advanced diagnostic techniques extend beyond structural imaging to electrophysiological and metabolic assessments. Electrocochleography (ECoG), an objective test measuring inner ear electrical potentials, is valuable for detecting endolymphatic hydrops, a condition linked to SNHL in disorders like Ménière's disease, with transtympanic tone-burst ECoG showing high sensitivity for cochlear hydrops. In research settings, positron emission tomography (PET) evaluates metabolic activity in auditory pathways, revealing glucose hypometabolism in the auditory cortex and inferior colliculus among patients with asymmetric or noise-induced SNHL, which correlates with the degree of hearing impairment.^[96]^[97]^[98]

Prevention

Lifestyle measures

Lifestyle measures play a crucial role in mitigating the risk of sensorineural hearing loss (SNHL) by addressing modifiable daily habits that influence inner ear health. These strategies focus on reducing exposure to damaging factors such as noise, oxidative stress, vascular impairments, and infections, supported by evidence from epidemiological and clinical studies. Adopting these practices can help preserve auditory function over time, particularly for individuals at higher risk due to age or environmental exposures.^[3]^[99] A primary lifestyle intervention involves noise avoidance to prevent noise-induced SNHL, which damages cochlear hair cells through mechanical and metabolic stress. Limiting exposure to sounds at or above 85 dBA is recommended, as prolonged or repeated exposure at this level can lead to permanent threshold shifts. For recreational settings like concerts, where sound levels often exceed 100 dBA, using earplugs provides effective protection; a randomized controlled trial demonstrated that earplugs significantly reduce temporary threshold shifts post-exposure, thereby lowering the cumulative risk of permanent hearing damage. Custom or high-fidelity earplugs that attenuate noise while preserving sound quality are particularly beneficial for frequent attendees.^[3]^[100]^[101] Dietary habits and overall health management also contribute to SNHL prevention by counteracting oxidative stress, a key pathophysiological mechanism in cochlear degeneration. Consuming antioxidant-rich foods high in vitamins A, C, and E—such as leafy greens, citrus fruits, nuts, and seeds—helps neutralize free radicals that damage inner ear structures; meta-analyses indicate that higher dietary intake of these antioxidants is inversely associated with hearing loss risk. Additionally, controlling chronic conditions like diabetes and hypertension through balanced diet, exercise, and medication adherence reduces vascular complications that impair cochlear blood flow and exacerbate SNHL. Effective glycemic control in diabetes, for instance, lowers the odds of auditory impairment by mitigating neuropathy and microangiopathy.^[99]^[102]^[103] Smoking cessation is another essential measure, as tobacco use promotes vascular damage and oxidative stress that accelerate SNHL progression. Current smokers exhibit higher rates of high-frequency hearing thresholds compared to non-smokers, with the risk linked to nicotine-induced vasoconstriction and inflammation in the cochlea. Quitting smoking diminishes this elevated risk over time, with longitudinal studies showing improved auditory outcomes and reduced hearing impairment severity among former smokers, particularly within years of cessation. Support programs combining counseling and pharmacotherapy enhance success rates for this modifiable behavior.^[104]^[105]^[106] Proper ear hygiene practices further safeguard against SNHL by preventing complications from trauma or infection. Individuals should avoid inserting cotton swabs into the ear canal, as this can push cerumen deeper, cause epithelial trauma, or perforate the tympanic membrane, potentially leading to infections and secondary hearing damage. Instead, ears self-clean through jaw movement, and excess wax can be managed by wiping the outer ear or seeking professional removal. Prompt treatment of ear infections, such as acute otitis media, is vital; untreated cases can spread to the inner ear in rare instances, causing labyrinthitis and sensorineural damage via inflammation or bacterial toxins. Early antibiotic therapy or drainage, guided by medical evaluation, minimizes these risks.^[107]^[108]^[109]

Occupational safeguards

Occupational safeguards against sensorineural hearing loss primarily target noise-induced damage through regulatory standards, workplace engineering, protective equipment, and monitoring in high-risk sectors. These measures aim to limit exposure to hazardous noise levels, which can cause irreversible cochlear hair cell damage and auditory nerve impairment. In the United States, the Occupational Safety and Health Administration (OSHA) enforces a permissible exposure limit of 90 decibels A-scale (dBA) as an 8-hour time-weighted average, requiring employers to implement feasible controls to prevent exceeding this threshold.^[110] When noise reaches the action level of 85 dBA over 8 hours, OSHA mandates a hearing conservation program that includes noise monitoring, employee training, and provision of hearing protectors at no cost.^[110] In the European Union, Directive 2003/10/EC sets lower and upper exposure action values at 80 dB and 85 dB, respectively, prompting employers to conduct risk assessments, measure exposure, and apply preventive measures; the exposure limit value is 87 dB, with mandatory health surveillance for affected workers.^[111] Engineering controls prioritize reducing noise at the source, such as through acoustic barriers, vibration-dampening materials on machinery, and substitution with quieter equipment, which can lower workplace levels by 10-20 dB or more depending on implementation.^[110] Integral to these efforts are hearing conservation programs, which require annual audiometric testing—baseline within 6 months of exposure and subsequent tests compared to detect standard threshold shifts of 10 dB or greater at 2,000, 3,000, or 4,000 Hz—to enable early intervention and program adjustments.^[110] Personal protective equipment serves as essential backup when engineering solutions are insufficient, with custom-molded earplugs and over-ear muffs typically attenuating noise by 15-30 dB when fitted correctly, though effectiveness depends on consistent use and proper seal.^[112] Employers must select devices based on noise levels and ensure training on fit and maintenance to achieve rated noise reduction ratings (NRR).^[113] These safeguards are critical in high-risk industries like construction, where about 14% of workers report hearing difficulties attributable to occupational noise from tools and machinery.^[114] Manufacturing sees similar vulnerabilities, with roughly 20% of noise-exposed workers experiencing hearing impairment due to prolonged exposure in assembly and processing environments.^[115] In the military, blast exposure from weapons and explosions poses acute risks, contributing to hearing loss in approximately 15% of active-duty personnel.^[116]

Management

Non-surgical options

Non-surgical management of sensorineural hearing loss (SNHL) primarily involves amplification devices, assistive technologies, rehabilitative therapies, and pharmacotherapy for acute cases, aiming to improve auditory perception and communication without invasive procedures. These approaches are recommended as first-line treatments for mild to moderate SNHL, where residual hearing can be effectively utilized.^[117] Hearing aids are the cornerstone of amplification for SNHL, consisting of digital devices that amplify specific frequencies tailored to the individual's audiogram to compensate for high-frequency losses commonly seen in this condition.^[118] Modern digital hearing aids process sound through programmable microchips, reducing background noise and enhancing speech clarity.^[119] Many individuals with mild to moderate SNHL experience significant benefit in speech understanding and quality of life from hearing aids, though outcomes depend on factors like degree of loss and user adaptation.^[120] Over-the-counter (OTC) hearing aids, approved by the U.S. Food and Drug Administration in 2022 for adults with self-perceived mild to moderate hearing loss, offer a self-fitting, affordable option without requiring a medical evaluation or professional adjustment.^[121]^[122] Common styles include behind-the-ear (BTE) aids, which sit comfortably behind the ear and connect via a tube to a custom earpiece, suitable for a wide range of losses; and in-the-canal (ITC) aids, which fit partially in the ear canal for a more discreet appearance and are ideal for mild to moderate cases.^[118] BTE models are versatile for children and those with dexterity issues, while ITC aids minimize occlusion effects.^[123] Assistive listening devices complement hearing aids in challenging environments, such as noisy group settings, by directly transmitting sound to the user.^[124] Frequency modulation (FM) systems, for example, use a microphone worn by the speaker to send wireless signals to a receiver connected to the hearing aid, improving signal-to-noise ratio by up to 15-20 dB and enhancing speech comprehension in reverberant or distant scenarios.^[125] Captioning devices, including real-time text displays for lectures, television, or phone calls, provide visual support for auditory input, particularly beneficial in educational or social gatherings where acoustic challenges persist despite amplification.^[126] These tools are often portable and can be used independently or integrated with hearing aids via telecoil technology.^[124] Aural rehabilitation focuses on training to optimize communication skills and psychological adjustment for those with SNHL.^[117] Speechreading, also known as lipreading, involves visual cues from facial movements to supplement auditory signals, with structured training improving recognition of consonants and words in noisy conditions.^[127] Auditory training programs, delivered through apps or clinician-guided sessions, enhance the brain's processing of amplified sounds, fostering better discrimination of phonemes and environmental noises; examples include software like LACE (Listening and Communication Enhancement) that progressively increases difficulty.^[127] Counseling components address emotional aspects, such as stigma or frustration, promoting acceptance and strategies for self-advocacy in conversations.^[128] These interventions, often combined with amplification, yield sustained improvements in social participation when initiated early.^[117] For acute inflammatory or sudden SNHL, pharmacotherapy with corticosteroids is a standard non-surgical intervention to reduce cochlear swelling and promote recovery.^[129] Oral prednisone, typically dosed at 1 mg/kg body weight daily (up to 60 mg) for 7-14 days followed by a taper, is administered promptly to maximize efficacy.^[130] Clinical studies indicate partial to complete hearing recovery in approximately 50-60% of cases when treatment begins within two weeks of onset, with better outcomes in milder losses.^[131] This approach is particularly effective for idiopathic sudden SNHL presumed to involve viral or autoimmune mechanisms.^[132] For severe or profound SNHL unresponsive to aids, evaluation for cochlear implant candidacy may be considered, but non-surgical options remain prioritized initially.

Surgical interventions

Surgical interventions for sensorineural hearing loss (SNHL) are typically reserved for cases of severe to profound bilateral loss where non-surgical options, such as hearing aids, provide insufficient benefit.^[133] These procedures aim to bypass damaged inner ear structures or enhance sound transmission, particularly when the auditory nerve remains functional.^[133] Common indications include profound SNHL exceeding 70 dB hearing threshold with poor speech discrimination scores below 50% in the better ear.^[133] Cochlear implants represent the primary surgical treatment for profound SNHL, involving the implantation of an electrode array directly into the cochlea to electrically stimulate the auditory nerve, thereby restoring some auditory perception.^[133] Candidates are generally adults or children with bilateral severe-to-profound SNHL who derive limited benefit from conventional amplification, often after audiometric confirmation of thresholds greater than 70 dB and word recognition scores under 50%.^[133] Post-implantation, approximately 80-90% of recipients demonstrate significant improvements in speech perception, particularly in quiet environments, enabling better communication and quality of life.^[134] Patients unresponsive to hearing aids are frequently referred for this intervention when rehabilitation goals cannot be met otherwise.^[133] Bone-anchored hearing aids (BAHA) are surgically implanted devices suitable for mixed hearing loss, where a conductive component overlays the sensorineural deficit, such as in chronic otitis media or congenital malformations.^[135] The procedure involves anchoring a titanium fixture to the skull behind the ear, which transmits vibrations through bone conduction to the functioning cochlea, bypassing outer and middle ear issues.^[135] Indications include air-bone gaps greater than 10 dB with underlying SNHL, typically in patients over age 5 who cannot tolerate traditional hearing aids due to skin sensitivities or poor acoustics.^[136] Outcomes often yield improved sound localization and speech understanding in noise for those with mixed losses.^[136] For cases where the auditory nerve is absent or nonfunctional, such as in neurofibromatosis type 2, auditory brainstem implants (ABI) provide an alternative by directly stimulating the cochlear nucleus in the brainstem.^[137] These are indicated for patients ineligible for cochlear implants due to bilateral auditory nerve loss, often following tumor resection, with implantation typically performed in individuals aged 12 or older.^[138] ABIs restore basic sound awareness and limited speech detection, though outcomes vary and generally offer less robust perception than cochlear implants.^[137] Stapedotomy, while primarily addressing conductive hearing loss in otosclerosis, is rarely applied when sensorineural involvement complicates the condition, aiming to improve overall auditory transmission by replacing the fixed stapes footplate.^[139] All surgical interventions carry risks, including infection rates of 2-5% that may necessitate device revision or removal, and facial nerve damage occurring in less than 1% of cases, potentially leading to temporary or permanent paresis.^[140] Meticulous surgical technique and preoperative imaging minimize these complications, with most resolving without long-term sequelae.^[141]

Prognosis

Factors influencing outcomes

Several factors influence the progression of sensorineural hearing loss (SNHL) and the success of interventions, enabling more personalized prognostic assessments. Early intervention plays a critical role, particularly in cases of sudden SNHL, where treatment initiation within 2 weeks of onset significantly enhances hearing recovery compared to later administration, as delayed treatment leads to diminished auditory improvement amplitude.^[142] In broader SNHL contexts, prompt amplification or implantation, especially in children, yields superior auditory performance and language development, with early cochlear implantation demonstrating statistically significant long-term benefits in speech perception and vocabulary acquisition.^[143] Additionally, bilateral symmetric hearing loss often responds more favorably to hearing aids than asymmetric or unilateral forms, with bilateral fitting improving speech recognition in noise and overall sound quality for the majority of users.^[144] Conversely, prolonged duration of untreated SNHL adversely affects outcomes by altering neural plasticity; hearing losses exceeding several years promote maladaptive cortical reorganization, reducing the efficacy of subsequent rehabilitation efforts.^[145] Comorbidities such as diabetes mellitus accelerate SNHL progression through mechanisms like microangiopathy and neuropathy, with affected individuals showing higher rates of bilateral sensorineural impairment and faster hearing threshold deterioration compared to non-diabetic populations.^[146]^[147] Severity at baseline also modulates treatment efficacy, notably in cochlear implantation, where preservation of residual low-frequency hearing post-surgery correlates with enhanced speech understanding in noisy environments and more natural sound perception, as electro-acoustic stimulation leverages remaining acoustic input for better overall outcomes.^[148] Outcomes differ markedly between pediatric and adult populations due to variations in neural plasticity. Children with early-onset SNHL who receive cochlear implants within the first few years of life often achieve near-normal speech production and receptive language skills, supported by heightened developmental plasticity that facilitates auditory integration.^[143] In contrast, adults with longstanding SNHL experience more variable improvements in speech perception following implantation, with untreated loss contributing to potential cognitive declines over time, though rehabilitation still yields benefits in communication and quality of life.^[149] Variability in sudden-onset cases underscores the importance of these factors, as detailed in specific etiological assessments.^[150]

Long-term impacts

Sensorineural hearing loss (SNHL) often leads to profound social consequences, including increased isolation as individuals withdraw from social settings such as group conversations or community events due to communication difficulties.^[151] This isolation is compounded by reduced employment opportunities, with systematic reviews indicating a higher likelihood of unemployment or underemployment among affected adults.^[152] Furthermore, untreated SNHL is associated with lower odds of employment compared to those with normal hearing, contributing to diminished income and financial strain.^[153] Relationship strain is also common, as persistent misunderstandings and frustration from impaired communication can escalate arguments and erode emotional bonds between partners or family members.^[154] On the health front, long-term SNHL elevates the risk of cognitive decline, with mild cases doubling the likelihood of dementia, moderate cases tripling it, and severe cases increasing it fivefold.^[155] A 2023 randomized trial (ACHIEVE study) found that hearing aids slowed the rate of cognitive decline by 48% over three years in older adults with hearing loss and elevated dementia risk.^[156] Balance issues arise from the vestibular involvement in the inner ear, with even mild untreated hearing loss tripling the risk of falls.^[157] Economically, unaddressed SNHL imposes a substantial global burden, estimated at over $980 billion annually in 2021, encompassing lost productivity, caregiving costs, and quality-of-life reductions.^[158] In the workforce, this manifests as decreased participation and output, particularly in communication-intensive roles, amplifying individual and societal financial pressures.^[158] Effective management through hearing aids or cochlear implants can substantially mitigate these impacts, with devices often restoring 70-90% of speech recognition function in suitable candidates, thereby reducing isolation, supporting employment, and lowering associated health risks.^[159]

Research

Gene and stem cell therapies

Gene therapy represents a promising avenue for treating hereditary forms of sensorineural hearing loss (SNHL), particularly those caused by mutations in genes essential for auditory function, such as otoferlin (OTOF). Adeno-associated virus (AAV) vectors are commonly employed to deliver functional copies of these genes directly to inner ear cells, aiming to restore protein expression and synaptic transmission in cochlear hair cells. Preclinical studies in animal models of OTOF deficiency have shown that AAV-mediated OTOF delivery leads to otoferlin expression in inner hair cells, resulting in partial or full restoration of auditory brainstem responses and improved hearing thresholds.^[160]^[161] A key example is SENS-501 (OTOF-GT), an investigational AAV-based therapy developed by Sensorion for children with OTOF-related congenital deafness. In non-human primate and rodent models, SENS-501 has demonstrated safe transduction of cochlear cells with sustained otoferlin expression, correlating with hearing recovery without significant off-target effects. The Phase 1/2 AUDIOGENE clinical trial advanced with completion of enrollment for the second cohort of infants aged 6-31 months by August 2025; initial data from the first cohort, announced in July 2025, confirmed good tolerability, no serious adverse events related to the therapy, and early efficacy signals including improved auditory responses in treated ears.^[162]^[163]^[164] For acquired SNHL, often resulting from ototoxic damage or noise exposure, gene therapy strategies emphasize regeneration of lost hair cells through targeted overexpression of transcription factors. ATOH1, a key regulator of hair cell differentiation, has been delivered via AAV vectors in preclinical models of cochlear injury, inducing supporting cells to transdifferentiate into functional hair cells. 2025 studies report enhanced auditory evoked potentials and hair cell counts in noise- or drug-exposed mice following ATOH1 overexpression, highlighting its role in promoting regeneration without tumorigenic risks observed in earlier approaches.^[165]^[166] Stem cell-based interventions complement gene therapy by providing cellular replacement for damaged cochlear structures. Induced pluripotent stem cell (iPSC)-derived otic progenitors, which mimic early inner ear precursors, have been transplanted into the cochlea to repair hair cell loss in preclinical models. Earlier work at the University of Sheffield showed that human iPSC-derived progenitors survive transplantation, migrate to sensory regions, differentiate into hair cell-like cells, and form synaptic connections in deafened mouse cochleae, leading to improved hearing recovery. Recent efforts from Sheffield, through spin-out Rinri Therapeutics, focus on iPSC-derived progenitors for auditory neuron regeneration; in 2025, Rinri announced plans for Phase 1 trials of Rincell-1 to treat severe hearing loss due to nerve damage. Ongoing preclinical work has optimized protocols for progenitor expansion and delivery, paving the way for clinical translation in regenerative therapies for both hereditary and acquired SNHL.^[167]^[168]^[169] Despite these advancements, several challenges hinder the widespread application of gene and stem cell therapies for SNHL. Immune responses to AAV vectors can elicit inflammation in the sensitive inner ear, potentially reducing transduction efficiency and causing transient hearing fluctuations, as observed in some primate studies. Delivery remains a critical barrier, requiring minimally invasive techniques like round window injection to avoid trauma to cochlear fluids and structures. Ethical concerns also arise, particularly regarding germline editing to correct heritable mutations, necessitating rigorous oversight to balance therapeutic benefits with risks of off-target genetic changes.^[170]^[171]^[172]

Pharmacological and regenerative approaches

Pharmacological interventions for sensorineural hearing loss (SNHL) focus on neuroprotective agents that mitigate damage to cochlear structures, particularly hair cells and synapses. Neurotrophins such as brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) have demonstrated protective effects against synaptic loss in preclinical models of ototoxicity and noise exposure. For instance, early transtympanic administration of recombinant human BDNF (rhBDNF) provides multifaceted neuroprotection, including preservation of synaptic ribbons and reduction of oxidative stress in cisplatin-induced hearing loss models.^[173] Similarly, NT-3 infused via hydrogels extends release and supports spiral ganglion neuron survival, enhancing auditory synapse integrity.^[174] The NOTOXIS Phase 2a trial of SENS-401 for preventing cisplatin-induced ototoxicity completed patient enrollment in March 2025, with topline results anticipated in late 2025.^[175] Antioxidant therapies target reactive oxygen species implicated in noise-induced and sudden SNHL. Ebselen, formulated as SPI-1005, reduces temporary and permanent threshold shifts in noise-induced hearing loss by inhibiting inflammatory pathways and protecting cochlear hair cells, as shown in phase 2 randomized trials.^[176] Phase 3 results from December 2024 confirmed SPI-1005's efficacy in improving auditory function in Meniere's disease, a condition often involving sensorineural components. Exploratory applications to sudden SNHL are supported by data from Meniere's and noise-induced models. By 2025, clinical data continued to highlight SPI-1005's role in mitigating acute noise-induced loss, supporting its potential as an oral preventive agent.^[177]^[178] Regenerative approaches leverage advanced delivery systems and scaffolds to promote hair cell and neuronal repair. Functionalized nanoparticles enable targeted cochlear delivery of therapeutics, overcoming the blood-labyrinth barrier for precise localization to auditory epithelium. In 2025 preclinical studies, these nanoparticles improved hair cell survival rates by up to 40% in ototoxic models through enhanced uptake and reduced off-target effects.^[179] Such systems also facilitate gene delivery for regeneration, though detailed mechanisms are addressed in gene therapy contexts.^[180] Biomaterial-based strategies, particularly hydrogels, mimic the inner ear's extracellular matrix to sustain drug release and foster cellular integration. Bioactive hydrogels loaded with neurotrophins or antioxidants enhance drug efficacy by providing controlled elution over weeks, reducing inflammation and supporting hair cell differentiation in organoid models.^[174] 2025 research demonstrated that dynamic click hydrogels improve stem cell adhesion and survival within the cochlear microenvironment, achieving greater than 50% integration rates in preclinical regeneration assays.^[181] These scaffolds not only amplify pharmacological effects but also promote endogenous repair by simulating native tissue stiffness and bioactivity.^[182] Integration of artificial intelligence (AI) in these approaches aids in developing predictive models for therapy personalization. Machine learning algorithms analyze genetic and audiometric data to forecast treatment responses in sudden SNHL, enabling tailored pharmacological regimens with accuracies exceeding 85% in 2025 validation studies.^[183] Such models prioritize candidates for neurotrophin or antioxidant interventions based on ototoxicity risk profiles, accelerating clinical decision-making.^[184]

Sudden sensorineural hearing loss

Presentation and initial assessment

Sudden sensorineural hearing loss (SSNHL) is defined as a hearing impairment of at least 30 decibels (dB) across three consecutive frequencies occurring within a 72-hour period. This condition is unilateral in approximately 90% of cases, distinguishing it from bilateral progressive forms of sensorineural hearing loss. Patients typically present with a abrupt onset of profound hearing loss, often described as a sudden "drop" in auditory perception that can range from mild to profound severity. Accompanying symptoms are common and include tinnitus in about 70% of individuals, which may manifest as ringing or buzzing in the affected ear, and vertigo or dizziness in 30-50% of cases, potentially indicating involvement of the vestibular system. While SSNHL shares some features with general sensorineural hearing loss symptoms, such as muffled hearing, its acute and rapid progression prompts immediate medical attention. Initial assessment begins with an urgent clinical history to identify potential precipitants, including recent viral infections, head trauma, or exposure to ototoxic medications. Physical examination includes otoscopy, which typically reveals a normal tympanic membrane without signs of middle ear effusion or external canal abnormalities, helping to differentiate SSNHL from conductive hearing loss. Bedside audiometry is performed promptly to confirm the sensorineural nature of the loss through air and bone conduction testing, often followed by referral for full audiometric evaluation if not immediately available. The differential diagnosis for SSNHL includes conditions such as Ramsay Hunt syndrome, characterized by herpes zoster infection with facial palsy and vesicular rash, and perilymph fistula, which may follow barotrauma or temporal bone fracture and present with fluctuating hearing loss alongside vertigo. Early recognition of these mimics is crucial, as they may require distinct management approaches beyond standard SSNHL protocols.

Etiology and risk factors

Sudden sensorineural hearing loss (SSNHL) is idiopathic in 85-90% of cases, with no identifiable cause despite extensive evaluation.^[185] Among the hypothesized etiologies for non-idiopathic cases, viral infections play a prominent role, particularly herpes simplex virus (HSV) and cytomegalovirus (CMV), which may trigger inner ear inflammation or direct cochlear damage.^[186]^[187] Vascular mechanisms, such as microcirculation occlusion leading to ischemia in the cochlea, are also frequently proposed, supported by histopathological evidence of reduced blood flow in affected inner ear structures.^[188]^[189] Several risk factors predispose individuals to SSNHL, including cardiovascular conditions like hypertension and hyperlipidemia, which are associated with an approximately 1.5- to 2-fold increased risk through promotion of vascular compromise.^[190]^[191] Autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis, elevate susceptibility by inducing immune-mediated cochlear injury.^[192] Recent upper respiratory infections further heighten risk, potentially via viral spread to the inner ear or secondary inflammatory responses, with epidemiological data showing a temporal association in up to 20-30% of cases.^[193]^[194] Less common etiologies include head trauma, which can result in perilymphatic fistula—a tear in the membranes separating the inner and middle ear, allowing perilymph leakage and sudden auditory disruption.^[195]^[196] Malignancy represents a rare cause, typically involving metastatic invasion of the temporal bone or acoustic nerve compression, as documented in isolated case reports.^[197] Some studies have reported associations between COVID-19 infection and SSNHL, though the incidence in COVID-19 patients is low (less than 1%), possibly due to viral neurotropism or hypercoagulability.^[198]

Diagnostic approach

The diagnosis of sudden sensorineural hearing loss (SSNHL) begins with a detailed history and physical examination to confirm the acute onset and sensorineural nature of the hearing deficit, followed by urgent audiometric evaluation to quantify the loss and differentiate it from conductive causes. Pure-tone audiometry (PTA) is the cornerstone, measuring thresholds across frequencies to identify a sensorineural loss of at least 30 dB over three or more contiguous frequencies that develops within 72 hours or less. Speech audiometry, including speech recognition threshold and word discrimination scores, is performed concurrently to assess functional hearing impairment, often revealing reduced discrimination disproportionate to pure-tone thresholds in SSNHL. Common audiometric configurations include flat (uniform loss across frequencies) or down-sloping (greater high-frequency involvement) patterns, which help characterize the loss but do not alter initial management urgency.^[199] Laboratory testing is not routinely recommended for all patients with SSNHL, as it rarely identifies a specific etiology and does not influence standard treatment; however, targeted tests are appropriate based on clinical suspicion to exclude mimics or risk factors. For suspected autoimmune processes, such as Cogan syndrome or systemic vasculitis, a complete blood count (CBC) to detect anemia or leukocytosis and erythrocyte sedimentation rate (ESR) to assess inflammation may be obtained. In cases with cardiovascular risk factors or suspicion of vascular compromise, a lipid profile can evaluate for hyperlipidemia as a potential contributor to cochlear ischemia. These tests should be guided by the patient's history, such as recent infections or comorbidities, rather than performed indiscriminately.^[199] Imaging plays a critical role in ruling out retrocochlear pathology or central causes that require immediate intervention. Clinicians should offer gadolinium-enhanced magnetic resonance imaging (MRI) of the internal auditory canal and cerebellopontine angle, particularly if asymmetric loss, vertigo, or neurological signs suggest tumor, stroke, or multiple sclerosis; this facilitates exclusion of treatable conditions like vestibular schwannoma or acute infarction. If MRI is unavailable or contraindicated, auditory brainstem response (ABR) testing serves as an alternative to screen for retrocochlear involvement. In the presence of head trauma or suspicion of temporal bone fracture, non-contrast computed tomography (CT) of the temporal bones is preferred for its superior bone detail.^[199] Advanced diagnostic tests are reserved for atypical presentations or to investigate specific etiologies when standard evaluations are inconclusive. Electrocochleography (ECochG), which measures the summating potential to action potential ratio via transtympanic electrode, can detect endolymphatic hydrops in patients with low-frequency predominant loss suggestive of early Meniere disease, aiding in targeted management. Blood tests for viral serology, such as IgM/IgG titers for herpes simplex, cytomegalovirus, or varicella-zoster, may be considered if prodromal symptoms like fever or rash indicate an infectious trigger, though yields are low in idiopathic cases. These modalities enhance diagnostic precision but are not first-line due to limited availability and specificity.

Therapeutic strategies

The primary therapeutic approach for sudden sensorineural hearing loss (SSNHL) involves systemic corticosteroids, typically administered as oral prednisone at a dose of 1 mg/kg/day (often around 60 mg daily) for 7-14 days followed by a taper over 10-14 days.^[200] This regimen is recommended by clinical practice guidelines as a first-line option for idiopathic cases, with evidence showing recovery rates of 50-65% when initiated within 2 weeks of symptom onset, particularly for mild to moderate hearing losses.^[201] Intratympanic corticosteroid injections, such as dexamethasone delivered directly to the middle ear, serve as an alternative primary treatment or adjunct to systemic therapy, offering targeted delivery with reduced systemic side effects and comparable efficacy in early intervention.^[202] Hyperbaric oxygen therapy (HBOT) is employed as an adjunctive treatment for idiopathic SSNHL, involving sessions in a pressurized chamber (typically 2.0-2.5 atmospheres absolute for 60-90 minutes daily over 10-20 sessions) to enhance oxygenation of the inner ear.^[203] Updated 2025 guidelines endorse HBOT within 14 days of onset in combination with steroids, demonstrating an additional 20-30% improvement in hearing recovery rates compared to steroids alone, especially in moderate to severe cases.^[204] Antiviral agents like acyclovir (typically 800 mg five times daily for 7-10 days) are considered only if a viral etiology such as herpes zoster oticus is clinically suspected, though systematic reviews indicate limited overall evidence for their routine use in idiopathic SSNHL, with no significant benefit over steroids alone in most cases. For refractory SSNHL—defined as incomplete response after 2 weeks of initial systemic therapy—salvage strategies focus on intratympanic dexamethasone injections (e.g., 4 mg/mL, 0.4-0.5 mL per session, 4-6 times over 1-2 weeks) or combination regimens including HBOT.^[205] Recent 2025 studies report partial hearing recovery in 25-40% of non-responders with these approaches, with intratympanic delivery showing superior outcomes in salvage settings due to higher local concentrations and lower systemic exposure.^[206] In cases of permanent profound deficit following failed interventions, cochlear implantation may be considered for auditory rehabilitation.^[200]

Outcomes and epidemiology

The incidence of sudden sensorineural hearing loss (SSNHL) ranges from 5 to 20 cases per 100,000 persons annually worldwide.^[207] Some studies suggest seasonal variations in incidence, with higher rates observed in winter potentially linked to increased viral infections.^[208] Spontaneous recovery occurs in 32% to 65% of SSNHL cases without intervention.^[209] Complete recovery is more likely in mild cases (hearing loss <50 dB), affecting approximately 50% of such patients, whereas profound hearing loss or delayed presentation beyond two weeks correlates with poor prognosis and lower recovery rates.^[210] In refractory SSNHL cases unresponsive to initial treatments, a 2025 meta-analysis reported complete recovery in only 9.6% of patients.^[205] Key prognostic factors include the presence of vertigo at onset, which approximately halves the odds of meaningful recovery (odds ratio 2.22), and younger age (<60 years), which is associated with improved outcomes.^[211]^[212] Long-term, approximately 30% of unresolved SSNHL cases progress to chronic sensorineural hearing loss, while tinnitus persists in about 40% of affected individuals.^[213]

References

[1]
Sensorineural Hearing Loss - StatPearls - NCBI Bookshelf
SNHL refers to any cause of hearing loss due to a pathology of the cochlea, auditory nerve, or central nervous system.Epidemiology · Evaluation · Treatment / Management · Differential Diagnosis
[2]
Hearing loss - Symptoms and causes - Mayo Clinic
Mar 30, 2023 · Dr. Carlson says just about all types of sensorineural hearing loss have to do with the loss of the function of hair cells in your inner ear. Dr ...
[3]
Noise-Induced Hearing Loss (NIHL) - NIDCD
Apr 16, 2025 · Noise-induced hearing loss (NIHL) occurs when the sensitive structures in the inner ear are damaged by loud sound.
[4]
Hearing Loss - StatPearls - NCBI Bookshelf - NIH
Hearing loss can be conductive, sensorineural, or mixed.[3] Conductive hearing loss takes place with disruption of the transmission of the sound waves to the ...
[5]
Sensorineural Hearing Loss: Symptoms, Causes & Treatment
Nov 15, 2024 · Unilateral sensorineural hearing loss affects one ear. Bilateral sensorineural hearing loss affects both ears. Asymmetrical sensorineural ...Missing: classification congenital acquired progressive stable
[6]
Types of Hearing Loss - CDC
May 15, 2024 · Sensorineural hearing loss. Hearing loss that occurs when there is a problem in the way the inner ear or hearing nerve works.
[7]
Deafness and hearing loss - World Health Organization (WHO)
Feb 26, 2025 · Disabling hearing loss refers to hearing loss greater than 35 decibels (dB) in the better hearing ear. Nearly 80% of people with disabling ...
[8]
The World Health Organization's hearing-impairment grading system
When the WHO HI grade system was established in 1991 there was little or no evidence available to develop such a system. Second, each grading system is based on ...
[9]
WHO: 1 in 4 people projected to have hearing problems by 2050
Mar 2, 2021 · Nearly 2.5 billion people worldwide ─ or 1 in 4 people ─ will be living with some degree of hearing loss by 2050, warns the World Health Organization's (WHO) ...
[10]
Age-Related Hearing Loss (Presbycusis) - NIDCD - NIH
Mar 17, 2023 · Age-related hearing loss (also called presbycusis, pronounced prez-buh-KYOO-sis) is hearing loss that occurs gradually for many of us as we grow older.<|separator|>
[11]
Quick Statistics About Hearing, Balance, & Dizziness - NIDCD - NIH
Sep 20, 2024 · The rate increases to 10% for adults ages 55-64. 22% of those ages 65-74 and 55% of those who are 75 and older have disabling hearing loss.
[12]
Gender differences in self-reported hearing loss and hearing aid use
Oct 2, 2025 · Though men were more likely than women to report hearing loss in nearly all countries, especially in regions with higher hearing aid use (USA, ...Missing: sensorineural | Show results with:sensorineural
[13]
Global, regional, and national burden of hearing loss from 1990 to ...
Global and locational burden of hearing loss. In 2021, the prevalence of hearing loss was 1,545,690,283 (95% UI: 1,480,358,023–1,618,714,974) cases, with ...
[14]
Syndromic Sensorineural Hearing Loss - StatPearls - NCBI Bookshelf
May 4, 2025 · Hearing loss, typically high-frequency and sensorineural, is the most common initial symptom of neurofibromatosis type 2.
[15]
Incidence of hearing loss following COVID-19 among young adults ...
Jul 29, 2024 · This study was conducted to determine the association of COVID-19 with HL and sudden sensorineural hearing loss (SSNHL) in young adults.
[16]
Presbycusis - StatPearls - NCBI Bookshelf - NIH
Worldwide, there are similar increases in prevalence with age. Presbycusis affects more than half of older adults by age 75 and nearly all adults over age 90.Missing: 65 | Show results with:65
[17]
Can Closed-Set Word Recognition Differentially Assess Vowel and ...
Oct 4, 2022 · Conversely, low-frequency hearing loss was expected to have a larger effect on vowel-variable word recognition and high-probability sentence ...
[18]
https://www.ncbi.nlm.nih.gov/books/NBK559220/
[19]
A Review of the Neurobiological Mechanisms that Distinguish ...
Apr 1, 2022 · Loudness recruitment is a common symptom of hearing loss induced by cochlear lesions, which is defined as an abnormally fast growth of loudness perception of ...
[20]
Prognosis of vestibular dysfunction in idiopathic sudden ... - PubMed
Background: Approximately 28%-57% of patients with idiopathic sudden sensorineural hearing loss (ISSNHL) have an acute vertigo attack and probable vestibular ...Missing: imbalance | Show results with:imbalance
[21]
Vestibular Dysfunction - StatPearls - NCBI Bookshelf - NIH
Symptoms typically consist of vertigo, nausea, vomiting, intolerance to head motion, unsteady gait, and postural instability, with nystagmus often clinically ...
[22]
Hearing loss and dementia in older adults: A narrative review
Meta-analysis of these three studies estimates that hearing loss is associated with nearly two times higher risk of dementia (pooled relative risk: 1.94, 95% CI ...
[23]
Psychological profile and social behaviour of working ... - PubMed
Working adults with a mild to moderate sensorineural hearing loss experience more negative emotional reactions and socio-situational limitations.<|control11|><|separator|>
[24]
Predictors of Hearing Aid Use in the Advanced Digital Era - PubMed
Background: Untreated sensorineural hearing loss (SNHL) has been linked to depression, social isolation, anxiety, and a reduction in health-related quality ...
[25]
Language Outcomes in Young Children with Mild to Severe Hearing ...
Children with mild to severe hearing loss, on average, showed depressed language levels compared to peers with normal hearing who were matched on age and ...
[26]
Approach to hearing loss - PMC - NIH
▸ Hearing loss has a profound effect on a patient's well-being, from academic underperformance in children to risk of falls and cognitive decline in the elderly ...
[27]
Self-Perception of Hearing Difficulties and Quality of Life ... - PubMed
Sep 29, 2022 · The results of the self-assessment questionnaires indicate that individuals with hearing loss can experience reduced quality of life, ...
[28]
(PDF) The Emotional and Social Impact of Hearing Loss
HHIA scores indicated that 74.3% experienced a severe overall handicap, with 72.1% reporting significant social impairment and 76.5% emotional impairment.
[29]
Carrier frequency of the GJB2 mutations that cause hereditary ...
Jul 16, 2015 · Approximately 1 in 1000 new-born children are affected by congenital hearing impairment, and 50–60% cases of them are attributable to genetic ...
[30]
Universal Newborn Hearing Screening - AAFP
May 1, 2007 · Congenital hearing loss is estimated to affect one in every 1,000 newborns. Causes of hearing loss can be conductive, sensorineural, mixed, ...
[31]
Forty-six genes causing nonsyndromic hearing impairment
The most frequent genes implicated in autosomal recessive nonsyndromic hearing loss are GJB2, which is responsible for more than half of cases.Missing: childhood | Show results with:childhood
[32]
Clinical aspects of hereditary hearing loss | Genetics in Medicine
The majority of genetic hearing loss diagnosed in infancy and early childhood is autosomal recessive in inheritance and nonsyndromic. Deafness at the DFNB1 ...
[33]
Nonsyndromic hearing loss - Genetics - MedlinePlus
Feb 1, 2016 · One common way is by the condition's pattern of inheritance: autosomal dominant (DFNA), autosomal recessive (DFNB), X-linked (DFNX), or ...
[34]
OTOF mutations revealed by genetic analysis of hearing loss ... - NIH
Non‐syndromic hearing loss accounts for 80% of genetic hearing loss in children, with mutations in DFNB1/GJB2 being by far the most common cause. Among the ...Missing: childhood | Show results with:childhood
[35]
Sensorineural hearing loss caused by mitochondrial dna mutations
The A1555G mutation causes increased susceptibility to aminoglycoside antibiotic-induced hearing loss as well as non-syndromic sensorineural hearing loss.
[36]
Usher syndrome: MedlinePlus Genetics
May 17, 2021 · The hearing loss is classified as sensorineural, which means that it is caused by abnormalities of the inner ear. The loss of vision is caused ...Missing: Waardenburg | Show results with:Waardenburg
[37]
Waardenburg Syndrome - Symptoms, Causes, Treatment | NORD
Some affected individuals may also have hearing impairment due to abnormalities of the inner ear (sensorineural deafness). Researchers have described ...
[38]
Noise-Induced Hearing Loss - MDPI
Approximately 16% of disabling hearing loss in adults globally is attributed to occupational noise, ranging from 7 to 21% across various geographic regions [16] ...
[39]
Global burden and trends of occupational noise-induced hearing ...
Sep 22, 2025 · Occupational noise is defined in the GBD as level 3 risk, referring to the proportion of the population ever occupationally exposed to 85 + dB ...
[40]
Aminoglycoside- and Cisplatin-Induced Ototoxicity - PubMed Central
This review provides a narrative derived from relevant papers describing factors contributing to (or increasing the risk of) aminoglycoside and cisplatin- ...
[41]
Ototoxicity in childhood: Recommendations of the CODEPEH ...
Cisplatin-related ototoxicity usually occurs in 23%–50% of adults and 60% of children,2, 9 but the reported percentages vary greatly (from 1.7% to 90.1%).
[42]
Ototoxicity: Overview, Aminoglycosides, Other Antibiotics
Apr 25, 2024 · Epidemiology. Ototoxicity is estimated to occur in 6-7% of patients taking loop diuretics. Occurrence of loop diuretic ototoxicity depends on ...
[43]
Hearing Loss - Ear, Nose, and Throat Disorders - Merck Manuals
Ototoxic medications can cause sensorineural hearing loss, and many also have vestibular toxicity. During the COVID-19 pandemic, many patients experienced an ...
[44]
https://pmc.ncbi.nlm.nih.gov/articles/PMC6579718/
[45]
Hearing Loss in COVID-19 Patients: An Audiological Profile of ...
Dec 24, 2024 · Among the 49 symptomatic patients, mild high-frequency sensorineural hearing loss was seen in 10 (20.4%) patients in the right and left ears, ...
[46]
Sensorineural Hearing Loss Treatment
Head trauma: Severe head injuries or skull fractures can damage the auditory nerve or inner ear structures, leading to SNHL. Infections or diseases: Viral or ...
[47]
Autoimmune sensorineural hearing loss: the otology–rheumatology ...
Feb 21, 2013 · Autoimmune sensorineural hearing loss (SNHL) is a rare clinical entity characterized by a progressive fluctuating bilateral asymmetric SNHL that develops over ...
[48]
Risk Stratification of Sensorineural Hearing Impairment in Preterm ...
Nov 13, 2024 · Prematurity is an independent risk factor for SNHI, with an increasing prevalence with decreasing gestational age (GA).
[49]
Neonatal hyperbilirubinemia as a risk factor for hearing loss.
Hyperbilirubinemia at birth is a risk factor associated with hearing loss. It is usually associated with other factors, which might have synergistic effects on ...
[50]
Identification of Perinatal Risk Factors for Auditory Neuropathy ...
The subjects with ANSD had statistically significant higher rates of prematurity, low birth weight, jaundice, and mechanical ventilation.
[51]
Inner Hair Cell Loss Disrupts Hearing and Cochlear Function ...
Jan 18, 2017 · There are three times as many outer hair cells (OHC) as inner hair cells (IHC), yet IHC transmit virtually all acoustic information to the brain ...Missing: motility | Show results with:motility
[52]
Cochlear amplification, outer hair cells and prestin - PubMed Central
Cylindrical outer hair cells are motile and their somatic length changes are voltage driven and powered by prestin. One of the central outstanding problems in ...Missing: sensorineural | Show results with:sensorineural
[53]
Response Growth With Sound Level in Auditory-Nerve Fibers After ...
The sharp tuning curves suggest that there is remaining OHC function. Thresholds elevated by less than 85 dB and low-medium SR were interpreted by Liberman ...Missing: mapping | Show results with:mapping
[54]
Dead Regions in the Cochlea: Diagnosis, Perceptual ...
Absolute thresholds more than 90 dB higher than normal (75–80 dB at low frequencies) are likely to be associated with a dead region in the cochlea. B. Effects ...
[55]
Mechanisms of sensorineural cell damage, death and survival in the ...
Following the activation of MAPK and ROS stress pathways, cochlear HCs can undergo apoptosis following intense noise exposure, aminoglycoside or cisplatin ...Missing: mechano- | Show results with:mechano-
[56]
Mechanisms of hair cell damage and repair - PMC - NIH
Sensory hair cells of the inner ear are exposed to continuous mechanical stress, causing damage over time. The maintenance of hair cells is further challenged ...
[57]
Mechanics of the Mammalian Cochlea - PMC - PubMed Central - NIH
Sensitivity, nonlinearity, and frequency tuning of basilar membrane responses to tones at basal sites of the cochlea. ... Basilar membrane tuning curves in the ...
[58]
Effects of sensorineural hearing loss on temporal coding of ...
Jan 29, 2013 · Noise and kanamycin-induced hearing losses are generally associated with reductions in cochlear sensitivity and broadened frequency tuning – ...
[59]
Cochlear Synaptopathy and Noise-Induced Hidden Hearing Loss
Sep 21, 2016 · Accumulated evidence has shown that the synapses between IHCs and type-I SGNs are sensitive to noise and the damage to this synapse is likely to ...
[60]
Synaptic ribbon dynamics after noise exposure in the hearing cochlea
Apr 6, 2024 · Moderate noise exposure induces cochlear synaptopathy, the loss of afferent ribbon synapses between cochlear hair cells and spiral ganglion neurons.
[61]
Auditory-nerve responses in mice with noise-induced cochlear ...
Cochlear synaptopathy is the noise-induced or age-related loss of ribbon synapses between inner hair cells (IHCs) and auditory-nerve fibers (ANFs).
[62]
Prevalence of auditory neuropathy spectrum disorder in ... - PubMed
Mild SNHL was seen in 29.6% of the individuals with ANSD; 55.5% had moderate SNHL; 7.4% had severe SNHL; and 7.5% had profound SNHL.
[63]
Acoustic neuroma - Symptoms and causes - Mayo Clinic
Jun 10, 2025 · An acoustic neuroma is a noncancerous tumor that develops on the main nerve leading from the inner ear to the brain.Missing: neuropathy spectrum
[64]
Auditory Neuropathy Spectrum Disorder - Symptoms, Causes ...
Aug 18, 2021 · Auditory neuropathy spectrum disorder (ANSD) is a newly described condition defined as a sensorineural hearing loss that affects a person's ability to hear or ...Missing: acoustic neuroma
[65]
Auditory Neuropathy Spectrum Disorders: From Diagnosis to ...
Auditory neuropathy spectrum disorder (ANSD) refers to a range of hearing impairments characterized by deteriorated speech perception, despite relatively ...3. Etiologies · 3.1. 2. Postsynaptic... · 3.1. 3. Auditory Neuropathy
[66]
Auditory Neuropathy Spectrum Disorders: A Scoping Review
Feb 11, 2025 · ANSD is a condition that affects the auditory pathway, specifically the transmission of sound signals from the ear to the brain.
[67]
Tinnitus and underlying brain mechanisms - PMC - PubMed Central
The primary hypothesis of cellular mechanisms underlying tinnitus development is that hearing loss leads to a down regulation of inhibition and reorganization ...
[68]
Cortical Tonotopic Map Changes in Humans Are Larger in Hearing ...
Apr 15, 2020 · Our findings show that functional reorganization of the auditory cortex is less pronounced in hearing loss with tinnitus than in hearing loss ...
[69]
Rescuing Auditory Temporal Processing with a Novel Augmented ...
Jun 21, 2021 · The effects of AAE on central auditory function, particularly in the face of hearing loss, may arise, at least in part, from homeostatic ...
[70]
Acute Vertigo & Hearing Loss From Vestibulocochlear Nerve Infarction
Oct 12, 2018 · We present a case illustrating a rare but significant finding of vestibulocochlear nerve infarction revealed by DWI-MRI.Missing: compression | Show results with:compression
[71]
Vestibular Dysfunctions in Sudden Sensorineural Hearing Loss
Background: Sudden sensorineural hearing loss (SSHL) not only involves cochlear function, but might also be accompanied by vestibular disturbances.
[72]
Hearing Loss in Adults: Differential Diagnosis and Treatment - AAFP
Jul 15, 2019 · Hearing loss is categorized as conductive, sensorineural, or mixed. Age-related sensorineural hearing loss (i.e., presbycusis) is the most ...
[73]
Audiogram Interpretation - StatPearls - NCBI Bookshelf - NIH
On an audiogram, pure SNHL is indicated by overlapping lines representing air conduction and bone conduction without any air-bone gaps >10 dB HL. SNHL may occur ...
[74]
Audiology Pure-Tone Testing: Overview, Indications, Contraindications
Sep 28, 2023 · Pure-tone audiometry is a behavioral test used to measure hearing sensitivity. [8] This measure involves the peripheral and central auditory systems.
[75]
Speech Audiometry - StatPearls - NCBI Bookshelf
Feb 17, 2025 · A higher WRS indicates better speech understanding, while scores below expected levels may suggest auditory processing difficulties or ...Introduction · Procedures · Indications · Normal and Critical Findings
[76]
Speech audiometry - Voyage au centre de l'audition
A score of 85-100% correct is considered normal when pure tone thresholds are normal (A), but it is common for WRS to decrease with increasing sensorineural ...<|control11|><|separator|>
[77]
Otoacoustic Emissions - StatPearls - NCBI Bookshelf - NIH
Apr 17, 2023 · When OAE are absent, there must be some dysfunction in the cochlea, although the degree of hearing loss is uncertain. Hearing Screening. The ...Continuing Education Activity · Introduction · Function · Issues of Concern
[78]
Auditory Brainstem Response - StatPearls - NCBI Bookshelf
Jan 12, 2023 · Auditory brainstem response helps diagnose suspected neurologic abnormalities of the 8th cranial nerve, the associated auditory pathways, and ...
[79]
Auditory Brainstem Response Audiometry - Medscape Reference
Feb 28, 2024 · Auditory brainstem response (ABR) audiometry is a neurologic test of auditory brainstem function in response to auditory (click) stimuli.Physiology · Waveform Components · Applications
[80]
Clinical Application of the Threshold Equalizing Noise Test in ... - NIH
Apr 17, 2015 · The threshold-equalizing noise (TEN) test is designed to detect conveniently the presence of DRs in clinical settings.
[81]
Threshold Equalizing Noise (TEN) Test - AC40 - Interacoustics
Oct 29, 2025 · The TEN test is a quick and easy way to identify cochlear dead regions. What is a cochlear dead region? A dead cochlear region is defined as ...Missing: sensorineural | Show results with:sensorineural
[82]
Sudden onset hearing loss – causes, investigations and management
Magnetic resonance imaging (MRI) with gadolinium contrast of the internal acoustic meatus and brain is essential in unilateral or asymmetrical SNHL (>15 dB) to ...
[83]
Predicting Abnormal MRI in Asymmetric Hearing Loss - JAMA Network
Feb 26, 2015 · An MRI of the brain and internal auditory canals with gadolinium is the most sensitive ... MRI in the detection of acoustic neuromas--a suggested ...
[84]
MR Imaging in Sudden Sensorineural Hearing Loss. Time to Talk
SSHL is suspected in patients with a sudden onset of generally unilateral decrease or loss of hearing, occurring instantaneously or rapidly developing over a ...
[85]
5. The Role Of Imaging In The Management Of Patients With ...
While gadolinium-enhanced MRI is the gold standard imaging modality for diagnosing VS, non-contrast, high-resolution MRI has the sensitivity to be utilized as a ...
[86]
MRI Screening of Internal Auditory Canal: Is Gadolinium Necessary?
Non-contrast high-resolution T2WI alone can detect ILSs with 84–100% sensitivity, suggesting that gadolinium may be unnecessary to exclude ILSs on screening ...
[87]
Acoustic Neuroma Diagnosis | Aaron Cohen-Gadol, MD
Aug 13, 2025 · The gold standard for diagnosing an acoustic neuroma is magnetic resonance imaging (MRI) with gadolinium contrast. This imaging technique ...
[88]
Imaging of sensorineural hearing loss: a pattern-based approach to ...
CT forms an ideal means to evaluate the bony details of the otic capsule and labyrinth and will also allow evaluating the course of the facial nerve canal and ...
[89]
Management of Temporal Bone Trauma - PMC - PubMed Central
Because these important sensory structures are located completely within the temporal bone, trauma to the bone can result in hearing loss and vertigo.
[90]
Post-traumatic Ossifying Labyrinthitis: A Case Report and Review of ...
Sep 26, 2025 · We present the case of a 22-year-old male who developed progressive sensorineural hearing loss after a motor vehicle accident. High-resolution ...
[91]
Tone Burst Electrocochleography for the Diagnosis of Clinically ...
Jun 16, 2017 · Transtympanic tone burst electrocochleography is to date the simplest, cheapest and most sensitive technique for detecting cochlear endolymphatic hydrops to ...Cochlear Microphonic · Tone Burst Studies In... · Vestibular Meniere's Disease
[92]
Electrocochleogram and Perilymphatic Pressure Measurement - Aetna
Trans-tympanic electrocochleography (ECOG) can be used to confirm cochlear involvement in hearing loss, and is an objective test for endolymphatic hydrops.
[93]
18F-FDG PET Imaging of the Inferior Colliculus in Asymmetric ...
Mar 1, 2020 · Our purpose was to use PET to evaluate the glucose metabolism of the inferior colliculus (IC) and primary auditory cortex (PAC) in patients with asymmetric ...Missing: sensorineural | Show results with:sensorineural
[94]
Effectiveness in Preventing Hearing Loss: Meta-Analysis of Dietary ...
Feb 10, 2024 · Conclusion: Dietary intake of vitamins and antioxidants was inversely associated with the risk of developing hearing loss. Individuals with a ...Missing: percentage | Show results with:percentage
[95]
Noise-Induced Hearing Loss - CDC
Jan 30, 2024 · Take precautions when noise is 85dBA or higher. NIOSH established a recommended exposure limit (REL) of 85 A-weighted decibels (dBA) averaged ...
[96]
The Effect of Earplugs in Preventing Hearing Loss From ... - PubMed
Only 1 well-conducted randomized clinical trial was found, which showed that wearing earplugs to concerts is effective in reducing postconcert threshold shifts.
[97]
Antioxidant vitamins and magnesium and the risk of hearing loss in ...
Conclusion: Dietary intakes of antioxidants and magnesium are associated with lower risks of hearing loss.Missing: ACE sensorineural
[98]
Associations between diabetes mellitus and sensorineural hearing ...
Sep 1, 2024 · Poor control and longer duration of diabetes are reported risk factors for SNHL (Gupta et al., 2019). Those with T2DM often develop hearing loss ...
[99]
Association of Cigarette Smoking With Audiometric Hearing ...
Jan 27, 2022 · Persistent smoking may be associated with worse hearing impairment in older adults; thus, quitting smoking at any time may be beneficial for hearing health.Missing: damage | Show results with:damage
[100]
Cigarette Smoking, Smoking Cessation and Risk of Hearing Loss in ...
Conclusions: The higher risk of hearing loss associated with smoking may diminish over time after quitting.Missing: reduces | Show results with:reduces
[101]
Synergistic effect of smoking on age-related hearing loss in ... - Nature
Nov 3, 2020 · According to the data in our study, cochlear damage due to chronic smoking may be reversed through cessation of smoking.
[102]
Is It Really Dangerous to Clean My Ears with Cotton Swabs?
Aug 1, 2018 · Cotton swabs can cause punctured ear drums and hearing loss. In severe cases, the cotton swab can damage many sensitive structures behind the ear canal.
[103]
The Dangers of Using Cotton Swabs for Ear Cleaning
Nov 5, 2024 · Cotton swabs often push it deeper into the ear canal. This can lead to a buildup of impacted wax, causing discomfort, pain, and even hearing loss.
[104]
Can Ear Infections Cause Hearing Loss? - Orange Coast ENT
May 2, 2024 · Sensorineural hearing loss: In rare cases, the infection can spread to the inner ear, damaging the sensitive hair cells involved in hearing.
[105]
1910.95 - Occupational noise exposure. | Occupational Safety and Health Administration
### Summary of OSHA Occupational Noise Exposure Standard (29 CFR 1910.95)
[106]
Directive 2003/10/EC - noise | Safety and health at work EU-OSHA
Nov 14, 2024 · The exposure action value is fixed at 80 decibels (lower value) and 85 decibels (upper value). The employer shall assess and, if necessary, ...
[107]
Personal Protective Equipment Hearing Protection (Appendix G)
The inside of the muff cup is lined with an acoustic foam which can reduce noise by as much as 15 to 30 decibels. Ear muffs are often used in conjunction with ...
[108]
Provide Hearing Protection | Noise and Hearing Loss - CDC
Feb 16, 2024 · Keep the following guidelines in mind: Aim for just enough noise reduction to bring exposure down to 75-85 dBA. Avoid overprotection.
[109]
Construction Statistics | Noise and Hearing Loss - CDC
Feb 1, 2024 · Approximately 14% of all Construction workers have hearing difficulty. · About 7% of all Construction workers have tinnitus. · About 25% of noise- ...
[110]
Overall Statistics – All U.S. Industries | Noise and Hearing Loss - CDC
May 31, 2024 · Approximately 12% of all workers have hearing difficulty.1 · About 8% of all workers have tinnitus.3 · About 20% of noise-exposed tested workers ...
[111]
https://osha.europa.eu/en/legislation/directives/82
[112]
https://ehs.ncsu.edu/personal-protective-equipment-ppe/hearing-protection-appendix-g/
[113]
Hearing Aids — Styles/Types & How They Work | NIDCD
Oct 11, 2022 · This type of hearing loss is called sensorineural hearing loss. The damage can occur as a result of disease, aging, or injury from noise or ...
[114]
Hearing Aid Benefit in Patients with Mild Sensorineural Hearing Loss
Although hearing aids can minimize the negative effects of SNHL, only about one in five persons with SNHL seeks help for communication problems. Many persons ...Missing: efficacy | Show results with:efficacy
[115]
Benefits from, Satisfaction with, and Self-Efficacy for Advanced ... - NIH
Jun 15, 2018 · ADT hearing aid users with MSNHL achieved excellent outcomes, but ongoing follow-up and counseling from hearing health care providers may be ...
[116]
Hearing aids: How to choose the right one - Mayo Clinic
Apr 4, 2025 · BTE hearing aids can connect to different earpiece styles. Many BTE hearing aids use a tube to connect the hearing aid to a custom earpiece ...
[117]
https://www.asha.org/practice-portal/professional-issues/aural-rehabilitation-for-adults/
[118]
Evidence for the Use of Hearing Assistive Technology by Adults - NIH
The studies reviewed provide strong evidence that the use of FM devices by adults with hearing loss results in better speech understanding in noise performance ...
[119]
Assistive Devices for People with Hearing or Speech Disorders
Nov 12, 2019 · Personal FM systems operate in the same way as larger scale systems and can be used to help people with hearing loss to follow one-on-one ...
[120]
Options for Auditory Training for Adults with Hearing Loss - PMC - NIH
Several auditory training programs that are readily accessible for adults with hearing loss, hearing aids, or cochlear implants are described.
[121]
Aural Rehabilitation for Adults - American Academy of Audiology
The goals of aural rehabilitation are to improve conversational ability and reduce limitations caused by hearing loss, improving quality of life.
[122]
Clinical Practice Guideline: Sudden Hearing Loss (Update) - PubMed
KAS 10-Intratympanic steroid therapy for salvage is recommended within 2 to 6 weeks following onset of sudden sensorineural hearing loss. The time to treatment ...Missing: rate | Show results with:rate
[123]
Comparing the use of high dose to standard dose corticosteroids for ...
Current ENT-UK guidelines suggest treatment with a dose of oral prednisolone 1mg/kg/day for 7 days then tapered over a further 5 days.
[124]
Oral steroid regimens for idiopathic sudden sensorineural hearing loss
Results: Overall, 35% of the patients recovered a clinically significant amount of hearing. Recovery was associated with immediate treatment (within 2 weeks ...Missing: rate | Show results with:rate
[125]
Oral steroid treatment of sudden sensorineural hearing loss - PubMed
Conclusions: Application of steroid medication significantly improves the recovery outcomes in cases of Severe Sudden Sensorineural Hearing Loss.Missing: rate | Show results with:rate
[126]
Cochlear Implants - StatPearls - NCBI Bookshelf - NIH
Jan 22, 2025 · This technology is a significant advancement, offering improved hearing and quality of life for individuals with severe to profound hearing loss ...Continuing Education Activity · Introduction · Indications · Preparation
[127]
Cochlear implantation outcomes in adults: A scoping review
May 5, 2020 · Cochlear implantation has become known as “the treatment of choice” for adults with severe to profound hearing loss. Wide variability exists ...
[128]
Bone-Anchored Hearing Aids (BAHA) - Cleveland Clinic
Conditions treated with BAHA hearing aid · Conductive or mixed hearing loss (when sound doesn't travel through your ear as it should). · Single-sided deafness ( ...
[129]
Bone-Anchored Hearing Aids - Medical Clinical Policy Bulletins
... mixed hearing loss. Indications for the BAHA include hearing loss from congenital ear problems, chronic suppurative otitis media, and in some cases ...
[130]
Auditory Brainstem Implants: Recent Progress and Future ... - Frontiers
Jan 28, 2019 · The auditory brainstem implant (ABI) is a neuroprosthetic device that provides hearing sensations to deaf patients who are ineligible for the cochlear implant ...<|separator|>
[131]
Cochlear Implants and Auditory Brainstem Implants - Aetna
Aetna considers an auditory brainstem implant (ABI) medically necessary in members 12 years of age or older who have lost both auditory nerves due to disease.
[132]
Stapes Surgery for Otosclerosis - StatPearls - NCBI - NIH
Aug 2, 2025 · The goal of stapes surgery is to restore normal transmission of acoustic vibrations to the cochlear fluid when stapes footplate fixation ...Continuing Education Activity · Introduction · Preparation · Technique or Treatment
[133]
Reliability and Complications of 500 Consecutive Cochlear ...
Dec 15, 2008 · The risk of severe infection (eventually requiring explantation) was 1.4% (7 of 500). There was 1 case of transient facial palsy following ...<|control11|><|separator|>
[134]
Benefits and Risks of Cochlear Implants - FDA
Feb 9, 2021 · Risks from the Surgical Implant Procedure · Injury to the facial nerve --this nerve goes through the middle ear to give movement to the muscles ...
[135]
Time from sudden sensory neural hearing loss to treatment as ... - NIH
The threshold for treatment initiation time is up to 2 weeks, after which the amplitude of hearing improvement decreases significantly.Missing: intervention rates
[136]
Children then, adults now: long-term outcomes—performance at 15 ...
Dec 14, 2023 · The results show that there is a positive effect, with statistical significance, of early implantation on auditory performance, and telephone use.
[137]
Degree of Hearing Loss Affects Bilateral Hearing Aid Benefits ... - NIH
The majority of respondents reported better speech recognition and better overall sound quality with bilateral hearing aids. In addition, most respondents ...
[138]
Functional to structural plasticity in unilateral sudden sensorineural ...
Dec 1, 2023 · A cortical plasticity after long-duration single side deafness (SSD) is advocated with neuroimaging evidence while little is known about the ...
[139]
Diabetes mellitus and hearing loss | Molecular Medicine | Full Text
Oct 24, 2023 · DM aggravates hearing loss The results showed that patients with T2DM had significantly higher rates of deafness progression than normal people ...
[140]
Diabetes mellitus and the incidence of hearing loss: a cohort study
Nov 5, 2016 · DM-related hearing loss has been described as a progressive, bilateral, sensorineural impairment with gradual onset predominantly affecting ...
[141]
https://www.fda.gov/medical-devices/cochlear-implants/benefits-and-risks-cochlear-implants
[142]
Speech and Language Outcomes in Adults and Children with ...
Aug 22, 2025 · Cochlear implants (CIs) represent a significant engineering and medical milestone in the treatment of hearing loss for both adults and children.
[143]
Sudden Sensorineural Hearing Loss: An Otologic Emergency - PMC
Early intervention in patients presenting before 3 days has given 77.8% complete type 1 recovery Idiopathic sudden sensory neural hearing loss is a medical ...
[144]
Hearing and sociality: the implications of hearing loss on social life
Oct 3, 2023 · Hearing loss later in life may result in isolation from social settings, including group dining and places of employment, and contribute to ...
[145]
Hearing loss and employment: a systematic review of the ...
May 29, 2020 · In addition to its effects on health, hearing loss has been postulated to impact work status negatively, via unemployment, underemployment and ...
[146]
Adults With Hearing Loss & Unemployment
Around 44% of adults with unaddressed hearing issues are unemployed, giving them a 20% lower odds of employment compared to a healthy hearing population.
[147]
The impact of hearing loss on relationships
Oct 18, 2021 · Hearing loss can lead to a breakdown in day-to-day communication among couples and can strain any relationship.
[148]
FAST FACTS: Hearing Loss & Dementia - ACHIEVE Study
One study found that people with a mild, moderate, and severe hearing loss, respectively, had a 2x, 3x, and 5x greater risk of being diagnosed with dementia ...
[149]
Hearing loss can make you more likely to fall - Starkey
Sep 22, 2023 · When we don't hear well, we increase our risk of falls by 30 percent, research has shown. Reasons may include less awareness over our surroundings caused by ...
[150]
Estimating the global costs of hearing loss - Taylor & Francis Online
Total global economic costs of hearing loss exceeded $981 billion. 47% of costs were related to quality of life losses, with 32% due to additional costs of poor ...
[151]
Improving quality of life in the elderly: hearing loss treatment ... - NIH
Jan 4, 2024 · They help to restore hearing function and communication abilities and may even delay cognitive decline [11]. Cochlear implants improve ...
[152]
Bilateral gene therapy in children with autosomal recessive deafness 9
Jun 5, 2024 · Gene therapy is a promising approach for hereditary deafness. We recently showed that unilateral AAV1-hOTOF gene therapy with dual ...
[153]
AAV-Mediated Gene Therapy Restores Hearing in Patients with ...
Jan 8, 2024 · This study is the first to demonstrate the safety and efficacy of AAV-OTOF in patients, expands and optimizes current OTOF-related gene therapy.
[154]
[PDF] SENS-501 Gene Therapy for Autosomal Recessive Non ... - Sensorion
Overall, SENS-501 is well tolerated and did not induce any macroscopic/organ weight changes or local/systemic microscopic findings at the end of the observation ...
[155]
Sensorion Finishes Enrolling Patients in Second Cohort of Its Phase ...
Aug 7, 2025 · The therapy is intended to restore hearing and support early speech development in children with OTOF-related congenital deafness.
[156]
Sensorion Announces Preliminary Positive Data from the First ...
Jul 1, 2025 · SENS-501 (OTOF-GT) is an innovative gene therapy program developed to treat a specific form of congenital deafness linked to mutations in the ...Missing: animal models
[157]
ATOH-1 Gene Therapy in Acquired Sensorineural Hearing Loss
Jun 12, 2025 · Acquired SNHL results from ototoxic damage to cochlear hair cells (HCs) and is typically irreversible due to their limited regenerative capacity ...Missing: overexpression | Show results with:overexpression
[158]
ATOH-1 Gene Therapy in Acquired Sensorineural Hearing Loss
Jun 30, 2025 · ATOH1 gene therapy shows promise for treating acquired SNHL. However, further clinical trials are essential to confirm these preclinical findings.
[159]
Engraftment of Human Stem Cell-Derived Otic Progenitors in the ...
The results from our study are a proof of principle; that transplantation of iPSC-derived-hOPCs may be a useful therapeutic strategy to repair the damaged ...Missing: Sheffield 2024 2025
[160]
Sensory stem cell biology and regeneration - University of Sheffield
We also have established the proof of concept that hESC-derived otic progenitors can repair the damaged cochlea. We demonstrated that transplanted cells can ...Missing: iPSC- 2024
[161]
On the verge of reversing deafness | Research - University of Sheffield
Researchers at Sheffield are developing a breakthrough stem cell-based therapy to reverse SNHL that involves repairing the damaged inner ear with auditory stem ...Missing: transplant 2024
[162]
Gene Therapy for the Inner Ear: Challenges and Promises - PMC - NIH
The challenges that have limited the applications of gene therapy are reviewed, as are ethical concerns. Finally, we discuss the promise of gene therapy to ...
[163]
Gene therapy for hearing loss: challenges and the promise of ...
This review will explore these challenges and offer a perspective on how epigenetic modulation has the potential to address them.
[164]
Article International expert consensus on gene therapy for hereditary ...
Oct 23, 2025 · This consensus provides the first globally endorsed framework for gene therapy in hereditary hearing loss. It standardizes clinical trial design ...
[165]
Early transtympanic administration of rhBDNF exerts a multifaceted ...
Oct 10, 2024 · Early transtympanic administration of rhBDNF exerts a multifaceted neuroprotective effect against cisplatin-induced hearing loss.Missing: Phase trials
[166]
Bioactive hydrogels for the reconstruction of sensorineural hearing ...
Oct 17, 2025 · A recent study coupled NT-3 with peptide from a PEG hydrogel to produce an injectable hydrogel, which has a longer release time of NT-3 and ...
[167]
Sensorion's SENS-401 Phase 2a Trial in Cisplatin-Induced ...
Jul 23, 2024 · This trial investigates the efficacy and safety of SENS-401 in preventing Cisplatin-Induced Ototoxicity (CIO). The DSMB reviewed safety data ...
[168]
Development of ebselen for the treatment of sensorineural hearing ...
Feb 19, 2021 · A unique investigational new drug called ebselen (SPI-1005), that is anti-inflammatory and neuroprotective, has been shown to reduce noise-induced and ...
[169]
Sound Pharma Announces Positive Phase 3 Results for the ...
Dec 10, 2024 · SPI-1005 is being developed for several neurotologic indications including noise-induced hearing loss and two types of ototoxicity (hearing loss ...
[170]
Development of Ebselen for the Treatment of Sensorineural Hearing ...
Aug 7, 2025 · Multiple phase 2 clinical trials have demonstrated the safety and efficacy of SPI-1005 in treating Meniere's disease and acute noise-induced ...Missing: track | Show results with:track
[171]
Recent Advances in Functionalized Nanoparticles for Targeted and ...
Jul 18, 2025 · These functionalized nanoparticles have demonstrated improved cochlear targeting and therapeutic outcomes in preclinical models of SNHL.Missing: survival | Show results with:survival
[172]
Nanotechnology-enhanced gene therapy for hearing loss
Aug 11, 2025 · These nanoparticles can encapsulate genetic material, protecting it from degradation and ensuring targeted delivery to specific cochlear cells.
[173]
Chemically defined and dynamic click hydrogels support hair cell ...
Jan 9, 2025 · Here, we implement an alternative, chemically defined, dynamic hydrogel to support the differentiation of human inner ear organoids.
[174]
Bioactive hydrogels for the reconstruction of sensorineural hearing ...
Oct 17, 2025 · Overall, bioactive hydrogels hold significant promise in advancing SNHL treatment, and further research is needed to facilitate their ...Missing: efficacy stem integration
[175]
Analysis of Genetic Polymorphisms in Sudden Sensorineural ...
Sep 18, 2025 · The deep learning CNN model exhibited superior performance in efficacy prediction, surpassing conventional models, and could assist in precision ...Missing: pharmacological | Show results with:pharmacological
[176]
Machine Learning Models for Predicting Sudden Sensorineural ...
Researchers have attempted to utilize ML models to predict the outcome of patients with sudden sensorineural hearing loss.Missing: personalized | Show results with:personalized
[177]
Sudden Sensorineural Hearing Loss - DynaMed
Apr 3, 2025 · idiopathic sudden sensorineural hearing loss; sudden hearing loss ... Causes. > 90% of cases reported to be idiopathic. 4. other specific ...
[178]
Sudden sensorineural hearing loss associated with herpes simplex ...
Sudden sensorineural hearing loss associated with herpes simplex virus type 1 infection ... Antiviral treatment of idiopathic sudden sensorineural hearing loss ...
[179]
Idiopathic sudden sensorineural hearing loss: etiopathogenic aspects
Several factors have been postulated to elicit the etiology of idiopathic sudden sensorineural hearing loss. ... CMV and herpes virus)33. Almost all the ...<|control11|><|separator|>
[180]
Etiological analysis of patients with sudden sensorineural hearing loss
Mar 30, 2023 · Sudden sensorineural hearing loss (SSNHL) is a multifactorial emergency disease. Until now, the etiology of SSNHL is still unknown.
[181]
Cardiovascular Risk Factors in Patients With Sudden Sensorineural ...
Mar 5, 2023 · The interruption of vascular supply to the inner ear is one of several proposed etiologies of sudden sensorineural hearing loss (SSNHL).
[182]
Cardiovascular Risk Factors in Patients With Sudden Sensorineural ...
Mar 5, 2023 · Cardiovascular Risk Factors in Patients With Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis · Authors · Affiliations.
[183]
Cardiovascular Risk Factors, Cerebral Small Vessel Disease, and ...
After sensitivity analysis including 10 articles, the odds ratio of having hypertension was 1.55 (95% CI 1.32–1.82, p < 0.00001) for patients with iSSNHL (shown ...
[184]
Sensorineural Hearing Loss in Autoimmune Diseases: A Systematic ...
Jul 1, 2023 · Analysis of risk factors for recurrent sudden sensorineural hearing loss. ... Sudden sensorineural hearing loss: an autoimmune disease?
[185]
Epidemiological Evidence for Upper Respiratory Infections as ... - NIH
Oct 10, 2024 · ... upper respiratory infection. The number of clinic or hospital visits ... Sudden Sensorineural Hearing Loss: A Case-Crossover ...
[186]
Association of Acute Upper Respiratory Tract Infections with Sudden ...
Oct 13, 2021 · Acute URIs increase SSNHL risk and are a potential risk factor for SSNHL. ... risk factors for sudden sensorineural hearing loss in adults.Missing: hyperlipidemia | Show results with:hyperlipidemia
[187]
Prevalence of perilymphatic fistula in patients with sudden-onset ...
Dec 21, 2023 · Another cause that has been implicated is perilymphatic fistula (PLF). ... Idiopathic sudden sensorineural hearing loss. N Engl J Med. 2008;359 ...Missing: malignancy | Show results with:malignancy
[188]
Perilymphatic Fistula: Practice Essentials, History of the Procedure ...
Jun 30, 2022 · Trauma is frequently cited as the cause of a perilymphatic fistula ... sudden sensorineural hearing loss with and without perilymphatic fistula.Practice Essentials · History of the Procedure · Pathophysiology · PresentationMissing: malignancy | Show results with:malignancy
[189]
Sudden Hearing Loss Linked to Metastatic Adenocarcinoma of the ...
Sudden sensorineural hearing loss (SSNHL) is defined as a decrease in hearing of 30 dB or greater involving at least 3 consecutive frequencies over 72 hours as ...
[190]
Sudden Hearing Loss Waves: The Effect of COVID-19 Infection and ...
Summary. Sudden sensorineural hearing loss (SSNHL) has emerged as a potential complication of COVID-19 infection and vaccination.
[191]
Sudden Sensorineural Hearing Loss in the COVID-19 Pandemic - NIH
Accumulating data indicate that patients with COVID-19 could be affected by sudden sensorineural hearing loss (SSNHL).Missing: 2023 2024
[192]
Clinical Practice Guideline: Sudden Hearing Loss (Update)
Aug 1, 2019 · This guideline update provides evidence-based recommendations for the diagnosis, management, and follow-up of patients who present with sudden hearing loss.
[193]
Clinical Practice Guideline: Sudden Hearing Loss (Update)
The purpose of this multidisciplinary CPG is to identify quality improvement opportunities in managing patients with sudden hearing loss and to create explicit ...Clinical Practice Guideline... · Guideline Development Group
[194]
Salvage treatment strategies for refractory sudden sensorineural ...
Jul 15, 2025 · This systematic review aims to assess the effectiveness of current salvage treatments for SSNHL unresponsive to first-line systemic ...
[195]
Interventions for sudden sensorineural hearing loss: a systematic ...
Oct 27, 2025 · The NICE guidelines recommend considering a steroid to treat idiopathic SSNHL (NICE 2018). Similar to the conclusions from AAO-HNS, the NICE ...
[196]
[PDF] Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss
Feb 20, 2025 · Clinical Practice Guidelines on the Use of HBOT for SSNHL ... Criteria: Hyperbaric Oxygen Therapy. https://wa- · provider ...
[197]
Hyperbaric Oxygen and Sudden Sensorineural Hearing Loss
Aug 1, 2025 · The AAO-HNS Clinical Practice Guideline for SSNHL has expanded to include HBOT in combination with SS as an “option” for treatment, but not as ...
[198]
Salvage treatment strategies for refractory sudden sensorineural ...
Jul 15, 2025 · (22) observed a significant improvement in a group of 21 patients treated with intratympanic dexamethasone compared to the control group of ...
[199]
Salvage treatment strategies for refractory sudden sensorineural ...
Jul 14, 2025 · Therapy led to a complete recovery in 13 patients (23.6%), with a mean hearing gain of 36.2%. Partial recovery was experienced by 10 patients ( ...
[200]
Sudden Hearing Loss - Medscape Reference
Apr 17, 2024 · Estimates of the annual incidence of sudden sensory hearing loss range from 5-20 cases per 100,000 persons. Many cases likely go unreported, and ...
[201]
Weather conditions and sudden sensorineural hearing loss
Jul 17, 2002 · Climatic or meteorological condition changes have been implicated in the pathogenesis of Idiopathic Sudden Sensorineural Hearing Loss (ISSHL).
[202]
Spontaneous Recovery Rates in Patients With Idiopathic Sudden ...
Jun 21, 2018 · In the literature, the spontaneous recovery rate of ISSHL is stated to be 32% to 65%. These percentages are quoted from studies from almost 40 ...
[203]
Mental health in adults with sudden sensorineural hearing loss
Recovery rates of patients with mild hearing losses, hearing losses > 50 dB and losses in the 90 dB region are 70%, 30%, and 10%, respectively [7], [8], [9].
[204]
Vertigo may worsen odds of recovery in sudden hearing loss
Jun 23, 2018 · There was a significant correlation for vertigo with a worse hearing recovery (odds ratio, 2.22; 95 percent confidence interval, 1.54 to 3.2).
[205]
Prognostic Factors for Recovery from Sudden Sensorineural ...
Mar 30, 2017 · Many prognostic factors have been reported for ISSNHL. More severe initial hearing loss, advanced age, vertigo, descending type of audiogram, ...Abstract · Introduction · Subjects and Methods · Results
[206]
Sudden sensorineural hearing loss: long-term follow-up results
Results: In the long-term period, hearing level remained stable 2 months after the onset of SSHL. Patients complained of persistent tinnitus (36%), fluctuant ...Missing: chronic | Show results with:chronic